Adriaan A. Lammertsma - Publications

Affiliations: 
VU University Medical Center, Amsterdam, Netherlands 

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Driessen RS, Bom MJ, van Diemen PA, Schumacher SP, Leonora RM, Everaars H, van Rossum AC, Raijmakers PG, van de Ven PM, van Kuijk CC, Lammertsma AA, Knuuti J, Ahmadi A, Min JK, Leipsic JA, et al. Incremental prognostic value of hybrid [15O]H2O positron emission tomography-computed tomography: combining myocardial blood flow, coronary stenosis severity, and high-risk plaque morphology. European Heart Journal Cardiovascular Imaging. 21: 1105-1113. PMID 32959061 DOI: 10.1093/Ehjci/Jeaa192  0.386
2020 Stadt EAvd, Yaqub M, Lammertsma AA, Poot AJ, Schober PR, Schuit RC, Smit EF, Bahce I, Hendrikse NH. Quantification of [18F]afatinib using PET/CT in NSCLC patients : a feasibility study Ejnmmi Research. 10: 1-9. PMID 32804306 DOI: 10.1186/S13550-020-00684-4  0.409
2020 Collij LE, Heeman F, Salvadó G, Ingala S, Altomare D, Wilde A, Konijnenberg E, van Buchem M, Yaqub M, Markiewicz P, Golla SSV, Wottschel V, Wink AM, Visser PJ, Teunissen CE, ... Lammertsma AA, et al. Multi-tracer model for staging cortical amyloid deposition using PET imaging. Neurology. PMID 32675080 DOI: 10.1212/Wnl.0000000000010256  0.328
2020 Yaqub M, Verweij NJF, Pieplenbosch S, Boellaard R, Lammertsma AA, van der Laken CJ. Quantitative Assessment of Arthritis Activity in Rheumatoid Arthritis Patients Using [C]DPA-713 Positron Emission Tomography. International Journal of Molecular Sciences. 21. PMID 32365551 DOI: 10.3390/Ijms21093137  0.349
2020 Rijnierse MT, Groeneveldt JA, van Campen JSJA, de Boer K, van der Bruggen CEE, Harms HJ, Raijmakers PG, Lammertsma AA, Knaapen P, Bogaard HJ, Westerhof BE, Noordegraaf AV, Allaart CP, de Man FS. Bisoprolol therapy does not reduce right ventricular sympathetic activity in pulmonary arterial hypertension patients. Pulmonary Circulation. 10: 2045894019873548. PMID 32363028 DOI: 10.1177/2045894019873548  0.342
2020 Verfaillie SC, Golla SS, Timmers T, Tuncel H, van der Weijden CW, Schober P, Schuit RC, van der Flier WM, Windhorst AD, Lammertsma AA, van Berckel BN, Boellaard R. Repeatability of parametric methods for [F]florbetapir imaging in Alzheimer's disease and healthy controls: A test-retest study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20915403. PMID 32321347 DOI: 10.1177/0271678X20915403  0.373
2020 Rijnierse MT, van der Lingen ACJ, de Haan S, Becker MAJ, Harms HJ, Huisman MC, Lammertsma AA, van de Ven PM, van Rossum AC, Knaapen P, Allaart CP. Value of CMR and PET in Predicting Ventricular Arrhythmias in Ischemic Cardiomyopathy Patients Eligible for ICD. Jacc. Cardiovascular Imaging. PMID 32305468 DOI: 10.1016/J.Jcmg.2020.01.026  0.359
2020 Heeman F, Yaqub M, Lopes Alves I, Heurling K, Bullich S, Gispert JD, Boellaard R, Lammertsma AA. Simulating the effect of cerebral blood flow changes on regional quantification of [F]flutemetamol and [F]florbetaben studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20918029. PMID 32281514 DOI: 10.1177/0271678X20918029  0.359
2020 Knudsen GM, Ganz M, Appelhoff S, Boellaard R, Bormans G, Carson RE, Catana C, Doudet D, Gee AD, Greve DN, Gunn RN, Halldin C, Herscovitch P, Huang H, Keller SH, ... Lammertsma AA, et al. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X20905433. PMID 32065076 DOI: 10.1177/0271678X20905433  0.368
2020 Verweij NJF, Yaqub M, Bruijnen STG, Pieplenbosch S, Ter Wee MM, Jansen G, Chen Q, Low PS, Windhorst AD, Lammertsma AA, Hoekstra OS, Voskuyl AE, van der Laken CJ. First in man study of [F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis. Scientific Reports. 10: 1047. PMID 31974480 DOI: 10.1038/S41598-020-57841-X  0.373
2020 Verweij NJF, Wee MT, Jongh JD, Zwezerijnen GCJ, Yaqub M, Boers M, Voskuyl A, Lammertsma AA, Lems W, Laken CJVd. Sat0551 Whole Body Macrophage Pet Imaging That Includes The Feet Can Provide Additional Information To Clinical Assessment In Patients With Early Rheumatoid Arthritis Annals of the Rheumatic Diseases. 79: 1233-1233. DOI: 10.1136/Annrheumdis-2020-Eular.4380  0.381
2019 Everaars H, van Diemen PA, Bom MJ, Schumacher SP, de Winter RW, van de Ven PM, Raijmakers PG, Lammertsma AA, Hofman MBM, van der Geest RJ, Götte MJ, van Rossum AC, Nijveldt R, Danad I, Driessen RS, et al. Comparison between quantitative cardiac magnetic resonance perfusion imaging and [O]HO positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31822958 DOI: 10.1007/S00259-019-04641-9  0.381
2019 Hagens MHJ, Golla SSV, Janssen B, Vugts DJ, Beaino W, Windhorst AD, O'Brien-Brown J, Kassiou M, Schuit RC, Schwarte LA, de Vries HE, Killestein J, Barkhof F, van Berckel BNM, Lammertsma AA. The P2X receptor tracer [C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31705174 DOI: 10.1007/S00259-019-04550-X  0.336
2019 Bom MJ, van Diemen PA, Driessen RS, Everaars H, Schumacher SP, Wijmenga JT, Raijmakers PG, van de Ven PM, Lammertsma AA, van Rossum AC, Knuuti J, Danad I, Knaapen P. Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion. European Heart Journal Cardiovascular Imaging. PMID 31620792 DOI: 10.1093/Ehjci/Jez258  0.385
2019 Bruijnen STG, Verweij NJF, Gent YYJ, Huisman MC, Windhorst AD, Kassiou M, van de Ven PM, Lammertsma AA, Hoekstra OS, Voskuyl AE, van der Laken CJ. Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers. Plos One. 14: e0222844. PMID 31553762 DOI: 10.1371/Journal.Pone.0222844  0.377
2019 Verburg N, Koopman T, Yaqub MM, Hoekstra OS, Lammertsma AA, Barkhof F, Pouwels PJW, Reijneveld JC, Heimans JJ, Rozemuller AJM, Bruynzeel AME, Lagerwaard F, Vandertop WP, Boellaard R, Wesseling P, et al. Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study. Neuro-Oncology. PMID 31550353 DOI: 10.1093/Neuonc/Noz180  0.309
2019 Rotteveel L, Poot AJ, Bogaard HJ, Ten Dijke P, Lammertsma AA, Windhorst AD. In vivo imaging of TGFβ signalling components using positron emission tomography. Drug Discovery Today. PMID 31494189 DOI: 10.1016/J.Drudis.2019.08.011  0.354
2019 Everaars H, de Waard GA, Schumacher SP, Zimmermann FM, Bom MJ, van de Ven PM, Raijmakers PG, Lammertsma AA, Götte MJ, van Rossum AC, Kurata A, Marques KMJ, Pijls NHJ, van Royen N, Knaapen P. Continuous thermodilution to assess absolute flow and microvascular resistance: validation in humans using [15O]H2O positron emission tomography. European Heart Journal. 40: 2350-2359. PMID 31327012 DOI: 10.1093/Eurheartj/Ehz245  0.372
2019 Verburg N, Koopman T, Yaqub M, Hoekstra OS, Lammertsma AA, Schwarte LA, Barkhof F, Pouwels PJW, Heimans JJ, Reijneveld JC, Rozemuller AJM, Vandertop WP, Wesseling P, Boellaard R, de Witt Hamer PC. Direct comparison of [C] choline and [F] FET PET to detect glioma infiltration: a diagnostic accuracy study in eight patients. Ejnmmi Research. 9: 57. PMID 31254208 DOI: 10.1186/S13550-019-0523-8  0.392
2019 Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31230910 DOI: 10.1016/J.Jalz.2019.02.004  0.386
2019 Jauw Y, o'Donoghue J, Zijlstra J, Hoekstra O, Menke-van der Houven van Oordt CW, Morschhauser F, Carrasquillo J, Zweegman S, Pandit-Taskar N, Lammertsma A, van Dongen G, Boellaard R, Weber W, Huisman M. Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31147401 DOI: 10.2967/Jnumed.118.224568  0.355
2019 Koopman T, Verburg N, Pouwels PJ, Wesseling P, Hoekstra OS, De Witt Hamer PC, Lammertsma AA, Yaqub M, Boellaard R. Quantitative parametric maps of O-(2-[F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19851878. PMID 31122112 DOI: 10.1177/0271678X19851878  0.328
2019 Driessen RS, Raijmakers PG, Danad I, Stuijfzand WJ, Schumacher SP, Lammertsma AA, van Rossum AC, van Royen N, Underwood SR, Knaapen P. Adenosine single-photon emission computed tomography-derived transient ischemic dilatation and ejection fraction reserve fail to predict multivessel coronary artery disease. Nuclear Medicine Communications. PMID 31107409 DOI: 10.1097/Mnm.0000000000001033  0.357
2019 Stuijfzand WJ, Schumacher SP, Driessen RS, Lammertsma AA, Bakker AL, Rijnierse MT, van Rossum AC, van de Ven PM, Nap A, Appelman Y, van Royen N, van Leeuwen MA, Lemkes JS, Raijmakers PG, Knaapen P. Myocardial Blood Flow and Coronary Flow Reserve During 3 Years Following Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent Implantation: The VANISH Trial. Jacc. Cardiovascular Interventions. PMID 31029616 DOI: 10.1016/J.Jcin.2019.03.004  0.342
2019 Heeman F, Yaqub M, Lopes Alves I, Heurling K, Berkhof J, Gispert JD, Bullich S, Foley C, Lammertsma AA. Optimized dual-time-window protocols for quantitative [F]flutemetamol and [F]florbetaben PET studies. Ejnmmi Research. 9: 32. PMID 30919133 DOI: 10.1186/S13550-019-0499-4  0.317
2019 Botman E, Raijmakers PGHM, Yaqub M, Teunissen B, Netelenbos C, Lubbers W, Schwarte LA, Micha D, Bravenboer N, Schoenmaker T, de Vries TJ, Pals G, Smit JM, Koolwijk P, Trotter DG, ... Lammertsma AA, et al. Evolution of heterotopic bone in fibrodysplasia ossificans progressiva: An [F]NaF PET/CT study. Bone. PMID 30858149 DOI: 10.1016/J.Bone.2019.03.009  0.387
2019 Kramer GM, Yaqub M, Vargas HA, Schuit R, Windhorst AD, van den Eertwegh A, van der Veldt A, Bergman A, Burnazi E, Lewis JS, Chua SS, Staton K, Beattie BJ, Humm JL, Davis ID, ... ... Lammertsma AA, et al. Assessment of simplified methods for quantification of F-FDHT uptake in patients with metastatic castration-resistant prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30850488 DOI: 10.2967/Jnumed.118.220111  0.408
2019 Lammertsma AA. Quantification of PET Studies. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 30644053 DOI: 10.1007/S12350-018-01583-X  0.394
2019 Netelenbos C, Botman E, Raijmakers PG, Lammertsma AA, Eekhoff MW. [18F] NaF PET/CT the first tool to diagnose chronic activity in FOP at all ages? Bone Abstracts. DOI: 10.1530/Boneabs.7.Oc26  0.343
2019 Everaars H, Van Diemen PA, Bom MJ, Schumacher SP, Van De Ven PM, Raijmakers PG, Lammertsma AA, Hofman MBM, Van Der Geest RJ, Gotte MJW, Van Rossum AC, Nijveldt R, Danad I, Driessen RS, Knaapen P. P5286Cardiac magnetic resonance for quantification of absolute myocardial blood flow: comparison with [15O]H2O positron emission tomography European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz746.0257  0.42
2019 Bom MJ, Driessen RS, Van Diemen PA, Everaars H, Schumacher SP, Van Rossum AC, Raijmakers PG, Lammertsma AA, Knuuti J, Ahmadi A, Min JK, Leipsic JA, Narula J, Danad I, Knaapen P. 5962Incremental prognostic value of hybrid PET-CT assessed myocardial blood flow, coronary stenosis severity and adverse plaque characteristics European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz746.0103  0.408
2018 Bom MJ, Schumacher SP, Driessen RS, Raijmakers PG, Everaars H, van Diemen PA, Lammertsma AA, van de Ven PM, van Rossum AC, Knuuti J, Mäki M, Danad I, Knaapen P. Impact of individualized segmentation on diagnostic performance of quantitative positron emission tomography for haemodynamically significant coronary artery disease. European Heart Journal Cardiovascular Imaging. PMID 30590493 DOI: 10.1093/Ehjci/Jey201  0.353
2018 Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, Schwarte L, Mintun MA, Devous MD, Schuit RC, Windhorst AD, Lammertsma AA, Yaqub M, van Berckel BN, Boellaard R. Parametric methods for [F]flortaucipir PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18820765. PMID 30569813 DOI: 10.1177/0271678X18820765  0.397
2018 Bruijnen STG, Chandrupatla DMSH, Giovanonni L, Neri D, Vugts DJ, Huisman MC, Hoekstra OS, Musters RJP, Lammertsma AA, van Dongen GA, Jansen G, Molthoff CFM, van der Laken CJ. F8-IL10: a new potential anti-rheumatic drug evaluated by a PET-guided translational approach. Molecular Pharmaceutics. PMID 30550295 DOI: 10.1021/Acs.Molpharmaceut.8B00982  0.333
2018 de Waard GA, Danad I, Petraco R, Driessen RS, Raijmakers PG, Teunissen PF, van de Ven PM, van Leeuwen MAH, Nap A, Harms HJ, Lammertsma AA, Davies JE, Knaapen P, van Royen N. Fractional flow reserve, instantaneous wave-free ratio, and resting Pd/Pa compared with [15O]H2O positron emission tomography myocardial perfusion imaging: a PACIFIC trial sub-study. European Heart Journal. PMID 30452609 DOI: 10.1093/Eurheartj/Ehy632  0.362
2018 Hagens MHJ, Golla SV, Wijburg MT, Yaqub M, Heijtel D, Steenwijk MD, Schober P, Brevé JJP, Schuit RC, Reekie TA, Kassiou M, van Dam AM, Windhorst AD, Killestein J, Barkhof F, ... ... Lammertsma AA, et al. In vivo assessment of neuroinflammation in progressive multiple sclerosis: a proof of concept study with [F]DPA714 PET. Journal of Neuroinflammation. 15: 314. PMID 30424780 DOI: 10.1186/S12974-018-1352-9  0.377
2018 Ashek A, Spruijt OA, Harms HJ, Lammertsma AA, Cupitt J, Dubois O, Wharton J, Dabral S, Pullamsetti SS, Huisman MC, Frings V, Boellaard R, de Man FS, Botros L, Jansen S, et al. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung. Circulation. Cardiovascular Imaging. 11: e007402. PMID 30354494 DOI: 10.1161/Circimaging.117.007402  0.327
2018 Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/Jnumed.118.211532  0.333
2018 van der Aart J, Yaqub M, Kooijman EJM, Bakker J, Langermans JAM, Schuit RC, Hofman MBM, Christiaans JAM, Lammertsma AA, Windhorst AD, van Berckel BNM. Evaluation of the Novel PET Tracer [C]HACH242 for Imaging the GluN2B NMDA Receptor in Non-Human Primates. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30306318 DOI: 10.1007/S11307-018-1284-X  0.38
2018 Everaars H, de Waard GA, Driessen RS, Danad I, van de Ven PM, Raijmakers PG, Lammertsma AA, van Rossum AC, Knaapen P, van Royen N. Doppler Flow Velocity and Thermodilution to Assess Coronary Flow Reserve: A Head-to-Head Comparison With [O]HO PET. Jacc. Cardiovascular Interventions. PMID 30268877 DOI: 10.1016/J.Jcin.2018.07.011  0.349
2018 Bom MJ, Driessen RS, Raijmakers PG, Everaars H, Lammertsma AA, van Rossum AC, van Royen N, Knuuti J, Mäki M, Danad I, Knaapen P. Diagnostic value of longitudinal flow gradient for the presence of haemodynamically significant coronary artery disease. European Heart Journal Cardiovascular Imaging. PMID 30212851 DOI: 10.1093/Ehjci/Jey129  0.356
2018 Wolters EE, Golla SSV, Timmers T, Ossenkoppele R, van der Weijden CWJ, Scheltens P, Schwarte L, Schuit RC, Windhorst AD, Barkhof F, Yaqub M, Lammertsma AA, Boellaard R, van Berckel BNM. A novel partial volume correction method for accurate quantification of [F] flortaucipir in the hippocampus. Ejnmmi Research. 8: 79. PMID 30112620 DOI: 10.1186/S13550-018-0432-2  0.36
2018 Koopman T, Verburg N, Schuit RC, Pouwels PJW, Wesseling P, Windhorst AD, Hoekstra OS, de Witt Hamer PC, Lammertsma AA, Boellaard R, Yaqub M. Quantification of O-(2-[F]fluoroethyl)-L-tyrosine kinetics in glioma. Ejnmmi Research. 8: 72. PMID 30066053 DOI: 10.1186/S13550-018-0418-0  0.374
2018 Raaphorst RM, Luurtsema G, Schokker CJ, Attia KA, Schuit RC, Elsinga PH, Lammertsma AA, Windhorst AD. Improving metabolic stability of fluorine-18 labeled verapamil analogs. Nuclear Medicine and Biology. 64: 47-56. PMID 30056279 DOI: 10.1016/J.Nucmedbio.2018.06.009  0.325
2018 van der Aart J, Golla SSV, van der Pluijm M, Schwarte LA, Schuit RC, Klein PJ, Metaxas A, Windhorst AD, Boellaard R, Lammertsma AA, van Berckel BNM. First in human evaluation of [F]PK-209, a PET ligand for the ion channel binding site of NMDA receptors. Ejnmmi Research. 8: 69. PMID 30054846 DOI: 10.1186/S13550-018-0424-2  0.373
2018 Groot C, Tolboom N, Ikonomovic MD, Lammertsma AA, Boon BDC, Barkhof F, Scheltens P, Klunk WE, Rozemuller AJM, Ossenkoppele R, van Berckel BNM. Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma. Journal of Alzheimer's Disease : Jad. PMID 30040724 DOI: 10.3233/Jad-180316  0.364
2018 Scheltens NME, van der Weijden K, Adriaanse SM, van Assema D, Oomen PP, Krudop WA, Lammertsma AA, Barkhof F, Koene T, Teunissen CE, Scheltens P, van der Flier WM, Pijnenburg YAL, Yaqub M, Ossenkoppele R, et al. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease. Neuroimage. Clinical. 19: 625-632. PMID 29984170 DOI: 10.1016/J.Nicl.2018.05.024  0.36
2018 Golla SS, Verfaillie SC, Boellaard R, Adriaanse SM, Zwan MD, Schuit RC, Timmers T, Groot C, Schober P, Scheltens P, van der Flier WM, Windhorst AD, van Berckel BN, Lammertsma AA. Quantification of [F]florbetapir: A test-retest tracer kinetic modelling study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18783628. PMID 29897009 DOI: 10.1177/0271678X18783628  0.364
2018 de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, et al. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. Jama Neurology. PMID 29889941 DOI: 10.1001/Jamaneurol.2018.1346  0.355
2018 Jauw YWS, Heijtel DF, Zijlstra JM, Hoekstra OS, de Vet HCW, Vugts DJ, Verheul HM, Boellaard R, Zweegman S, van Dongen GAMS, der Houven van Oordt CWM, Lammertsma AA, Huisman MC. Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29713958 DOI: 10.1007/S11307-018-1200-4  0.351
2018 Driessen RS, Danad I, Stuijfzand WJ, Schumacher SP, Knuuti J, Mäki M, Lammertsma AA, van Rossum AC, van Royen N, Raijmakers PG, Knaapen P. Impact of Revascularization on Absolute Myocardial Blood Flow as Assessed by Serial [O]HO Positron Emission Tomography Imaging: A Comparison With Fractional Flow Reserve. Circulation. Cardiovascular Imaging. 11: e007417. PMID 29703779 DOI: 10.1161/Circimaging.117.007417  0.349
2018 Janssen B, Vugts DJ, Wilkinson SM, Ory D, Chalon S, Hoozemans JJM, Schuit RC, Beaino W, Kooijman EJM, van den Hoek J, Chishty M, Doméné A, Van der Perren A, Villa A, Maggi A, ... ... Lammertsma AA, et al. Identification of the allosteric P2X receptor antagonist [C]SMW139 as a PET tracer of microglial activation. Scientific Reports. 8: 6580. PMID 29700413 DOI: 10.1038/S41598-018-24814-0  0.338
2018 Chandrupatla DMSH, Jansen G, Mantel E, Low PS, Matsuyama T, Musters RP, Windhorst AD, Lammertsma AA, Molthoff CFM, van der Laken CJ. Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [F]Fluoro-PEG-Folate. Contrast Media & Molecular Imaging. 2018: 8092781. PMID 29681783 DOI: 10.1155/2018/8092781  0.341
2018 Vargas HA, Kramer GM, Scott AM, Weickhardt A, Meier AA, Parada N, Beattie BJ, Humm JL, Staton KD, Zanzonico PB, Lyashchenko SK, Lewis JS, Yaqub M, Sosa RE, van den Eertwegh AJ, ... ... Lammertsma AA, et al. Reproducibility and repeatability of semi-quantitativeF-fluorodihydrotestosterone (FDHT) uptake metrics in castration-resistant prostate cancer metastases: a prospective multi-center study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29626121 DOI: 10.2967/Jnumed.117.206490  0.365
2018 Timmers T, van Berckel BNM, Lammertsma AA, Ossenkoppele R. Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography. Methods in Molecular Biology (Clifton, N.J.). 1750: 221-229. PMID 29512076 DOI: 10.1007/978-1-4939-7704-8_15  0.354
2018 Jauw YWS, Huisman MC, Nayak TK, Vugts DJ, Christen R, Naegelen VM, Ruettinger D, Heil F, Lammertsma AA, Verheul HMW, Hoekstra OS, van Dongen GAMS, Menke-van der Houven van Oordt CW. Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody. Ejnmmi Research. 8: 6. PMID 29356983 DOI: 10.1186/S13550-018-0358-8  0.303
2018 Bruijnen STG, Verweij NJF, van Duivenvoorden LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, et al. Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography. Rheumatology (Oxford, England). PMID 29329443 DOI: 10.1093/Rheumatology/Kex448  0.344
2018 Verweij N, Bruijnen S, Rasch L, Turk S, Yaqub M, Lammertsma A, Hoekstra O, Schaardenburg Dv, Voskuyl A, Lems W, Laken Cvd. FRI0561 Macrophage pet imaging for predicting treatment outcome of de novo rheumatoid arthritis Annals of the Rheumatic Diseases. 77: 805-805. DOI: 10.1136/Annrheumdis-2018-Eular.4476  0.352
2018 Everaars H, De Waard GA, Driessen RS, Danad I, Raijmakers PG, Lammertsma AA, Van Rossum AC, Knaapen P, Van Royen N. 4172Doppler flow velocity and thermodilution to assess coronary flow reserve: head-to head comparison with [15O]H2O PET imaging European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy563.4172  0.327
2018 Driessen R, Danad I, Stuijfzand W, Schumacher S, Knuuti J, Lammertsma A, van Rossum A, Van Royen N, Raijmakers P, Knaapen P. IMPACT OF REVASCULARIZATION ON ABSOLUTE MYOCARDIAL BLOOD FLOW AS ASSESSED BY SERIAL [15O]H2O PET IMAGING: A COMPARISON WITH FRACTIONAL FLOW RESERVE Journal of the American College of Cardiology. 71: A1480. DOI: 10.1016/S0735-1097(18)32021-7  0.358
2018 Collij L, Konijnenberg E, Reimand J, Kate Mt, Braber Ad, Alves IL, Zwan MD, Yaqub MM, Assema Dv, Wink AM, Lammertsma AA, Scheltens P, Visser PJ, Barkhof F, Berckel BNMv. Assessment Of Early Amyloid Pathology Using [18F]Flutemetamol Positron Emission Tomography: Comparing Visual Read, Semi-Quantitative And Quantitative Methods Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2069  0.352
2018 Verfaillie SCJ, Golla SSV, Weijden CWJvd, Timmers T, Schober P, Schuit RC, Windhorst AD, Scheltens P, Flier WMVd, Lammertsma AA, Berckel BNMv, Boellaard R. Parametric Imaging Of [18F]Florbetapir: A Test-Retest Study In Healthy Subjects And Patients With Alzheimer’S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1801  0.306
2018 Everaars H, de Waard G, Schumacher S, Zimmermann F, van de Ven P, Lammertsma A, Götte M, Kurata A, Marques K, van Royen N, Knaapen P. TCT-94 Continuous infusion of saline for assessment of absolute hyperemic flow and minimal microvascular resistance: validation in humans using [15O]H2O PET Journal of the American College of Cardiology. 72: B41. DOI: 10.1016/J.Jacc.2018.08.1191  0.31
2018 Lammertsma A. [I103] The case for quantitative imaging in nuclear medicine Physica Medica. 52: 40. DOI: 10.1016/J.Ejmp.2018.06.175  0.404
2017 Bom MJ, Driessen RS, Stuijfzand WJ, Raijmakers PG, Van Kuijk CC, Lammertsma AA, van Rossum AC, van Royen N, Knuuti J, Mäki M, Nieman K, Min JK, Leipsic JA, Danad I, Knaapen P. Diagnostic Value of Transluminal Attenuation Gradient for the Presence of Ischemia as Defined by Fractional Flow Reserve and Quantitative Positron Emission Tomography. Jacc. Cardiovascular Imaging. PMID 29248645 DOI: 10.1016/j.jcmg.2017.10.009  0.404
2017 Golla SSV, Adriaanse SM, Yaqub M, Windhorst AD, Lammertsma AA, van Berckel BNM, Boellaard R. Model selection criteria for dynamic brain PET studies. Ejnmmi Physics. 4: 30. PMID 29209862 DOI: 10.1186/S40658-017-0197-0  0.333
2017 Verheijen RB, Yaqub MM, Sawicki E, van Tellingen O, Lammertsma AA, Nuijen B, Schellens JHM, Beijnen JH, Huitema ADR, Hendrikse NH, Steeghs N. Molecular Imaging of ABCB1/ABCG2 Inhibition at the Human Blood Brain Barrier using Elacridar and 11C-Erlotinib PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29175983 DOI: 10.2967/Jnumed.117.195800  0.372
2017 Raaphorst RM, Savolainen H, Cantore M, van de Steeg E, van Waarde A, Colabufo NA, Elsinga PH, Lammertsma AA, Windhorst AD, Luurtsema G. Comparison of In Vitro Assays in Selecting Radiotracers for In Vivo P-Glycoprotein PET Imaging. Pharmaceuticals (Basel, Switzerland). 10. PMID 29036881 DOI: 10.3390/Ph10030076  0.348
2017 Koopman T, Yaqub M, Heijtel DF, Nederveen AJ, van Berckel BN, Lammertsma AA, Boellaard R. Semi-quantitative cerebral blood flow parameters derived from non-invasive [(15)O]H2O PET studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17730654. PMID 28901822 DOI: 10.1177/0271678X17730654  0.398
2017 Eekhoff EMW, Botman E, Coen Netelenbos J, de Graaf P, Bravenboer N, Micha D, Pals G, de Vries TJ, Ton Schoenmaker T, Hoebink M, Lammertsma A, Raijmakers P. [18F]NaF PET/CT scan as an early marker of heterotopic ossification in fibrodysplasia ossificans progressiva. Bone. PMID 28826841 DOI: 10.1016/J.Bone.2017.08.012  0.373
2017 Danad I, Raijmakers PG, Driessen RS, Leipsic J, Raju R, Naoum C, Knuuti J, Mäki M, Underwood RS, Min JK, Elmore K, Stuijfzand WJ, van Royen N, Tulevski II, Somsen AG, ... ... Lammertsma AA, et al. Comparison of Coronary CT Angiography, SPECT, PET, and Hybrid Imaging for Diagnosis of Ischemic Heart Disease Determined by Fractional Flow Reserve. Jama Cardiology. PMID 28813561 DOI: 10.1001/Jamacardio.2017.2471  0.397
2017 Raaphorst RM, Luurtsema G, Schuit RC, Kooijman EJM, Elsinga PH, Lammertsma AA, Windhorst AD. Synthesis and evaluation of new fluorine-18 labeled verapamil analogs to investigate the function of P-glycoprotein in the blood-brain barrier. Acs Chemical Neuroscience. PMID 28650628 DOI: 10.1021/Acschemneuro.7B00086  0.346
2017 Chandrupatla DMSH, Jansen G, Vos R, Verlaan M, Chen Q, Low PS, Windhorst AD, Lammertsma AA, van der Laken CJ, Molthoff CFM. In-vivo monitoring of anti-folate therapy in arthritic rats using [(18)F]fluoro-PEG-folate and positron emission tomography. Arthritis Research & Therapy. 19: 114. PMID 28569209 DOI: 10.1186/S13075-017-1325-X  0.371
2017 Lammertsma AA. Forward to the Past: the Case for Quantitative PET Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28522743 DOI: 10.2967/Jnumed.116.188029  0.398
2017 Hagens MH, Killestein J, Yaqub MM, van Dongen GA, Lammertsma AA, Barkhof F, van Berckel BN. Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517704507. PMID 28443358 DOI: 10.1177/1352458517704507  0.332
2017 Golla SSV, Lubberink M, van Berckel BNM, Lammertsma AA, Boellaard R. Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising. Ejnmmi Research. 7: 36. PMID 28432674 DOI: 10.1186/S13550-017-0284-1  0.372
2017 Golla SS, Timmers T, Ossenkoppele R, Groot C, Verfaillie S, Scheltens P, van der Flier WM, Schwarte L, Mintun MA, Devous M, Schuit RC, Windhorst AD, Lammertsma AA, Boellaard R, van Berckel BN, et al. Quantification of Tau Load Using [(18)F]AV1451 PET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28374171 DOI: 10.1007/S11307-017-1080-Z  0.331
2017 van der Aart J, van der Doef TF, Horstman P, Huisman MC, Schuit RC, van Lingen A, Windhorst AD, van Berckel BN, Lammertsma AA. Human Dosimetry of the NMDA Receptor Ligand [(11)C]GMOM. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28183990 DOI: 10.2967/Jnumed.116.188250  0.323
2017 Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P. Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia. Alzheimer's Research & Therapy. 9: 2. PMID 28093088 DOI: 10.1186/S13195-016-0228-4  0.36
2017 Bruijnen S, Verweij N, Duivenvoorde Lv, Bravenboer N, Baeten D, Denderen Cv, van IdH, Voskuyl A, Ven Pvd, Boden B, Lammertsma A, Hoekstra O, Raijmakers P, Laken Cvd. FRI0623 [18F]fluoride PET-CT imaging of bone formation in ankylosing spondylitis before and after 12 weeks of ANTI-TNF treatment Annals of the Rheumatic Diseases. 76: 724-725. DOI: 10.1136/Annrheumdis-2017-Eular.2004  0.364
2017 Driessen R, Stuijfzand W, Raijmakers P, Danad I, Min J, Leipsic J, Ahmadi A, Narula J, van de Ven P, Huisman M, Lammertsma A, van Rossum A, Van Royen N, Knaapen P. ATHEROSCLEROTIC PLAQUE MORPHOLOGY IS ASSOCIATED WITH IMPAIRED MYOCARDIAL BLOOD FLOW AND FRACTIONAL FLOW RESERVE, INDEPENDENT OF LUMINAL OBSTRUCTION Journal of the American College of Cardiology. 69: 1403. DOI: 10.1016/S0735-1097(17)34792-7  0.305
2017 Wilde Ad, Flier WMvd, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Teunissen CE, Stephens A, Lammertsma AA, Berckel BNMv, Scheltens P. CONCORDANCE BETWEEN CEREBROSPINAL FLUID AMYLOID-β AND [ 18 F]FLORBETABEN PET IN AN UNSELECTED COHORT OF MEMORY CLINIC PATIENTS Alzheimers & Dementia. 13: 688. DOI: 10.1016/J.Jalz.2017.06.2277  0.309
2016 Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Jafari L, Lammertsma AA, Law I, et al. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18 F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27987029 DOI: 10.1007/S00259-016-3598-8  0.358
2016 Morbelli S, Arbizu J, Booij J, Chen MK, Chetelat G, Cross DJ, Djekidel M, Drzezga A, Ekmekcioglu O, Garibotto V, Hesse S, Ishii K, Saraf LJ, Lammertsma AA, Law I, et al. The need of standardization and of large clinical studies in an emerging indication of [(18)F]FDG PET: the autoimmune encephalitis. European Journal of Nuclear Medicine and Molecular Imaging. PMID 27924371 DOI: 10.1007/S00259-016-3589-9  0.366
2016 van der Wildt B, Wilhelmus MM, Kooijman EJ, Jongenelen CA, Schuit RC, Büchold C, Pasternack R, Lammertsma AA, Drukarch B, Windhorst AD. Development of fluorine-18 labeled peptidic PET tracers for imaging active tissue transglutaminase. Nuclear Medicine and Biology. 44: 90-104. PMID 27837727 DOI: 10.1016/J.Nucmedbio.2016.10.002  0.309
2016 Mansor MS, Yaqub M, Boellaard R, Froklage FE, Vries A, Bakker ED, Voskuyl RA, Eriksson J, Schwarte LA, Verbeek J, Windhorst AD, Lammertsma A. Parametric methods for dynamic 11C-Phenytoin PET studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27660142 DOI: 10.2967/Jnumed.116.178707  0.381
2016 van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BN. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. Npj Schizophrenia. 2: 16031. PMID 27602389 DOI: 10.1038/Npjschz.2016.31  0.386
2016 Stuijfzand WJ, Driessen RS, Raijmakers PG, Rijnierse MT, Maeremans J, Hollander MR, Lammertsma AA, van Rossum AC, Dens J, Nap A, van Royen N, Knaapen P. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. European Heart Journal Cardiovascular Imaging. PMID 27585716 DOI: 10.1016/S0735-1097(16)30146-2  0.38
2016 Stuijfzand WJ, Raijmakers PG, Driessen RS, Lammertsma AA, van Rossum AC, Nap A, Appelman Y, Lemkes JS, van Leeuwen MA, van Royen N, Knaapen P. Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 12: e584-94. PMID 27497358 DOI: 10.1016/S0735-1097(16)30227-3  0.324
2016 Makris NE, Boellaard R, Menke CW, Lammertsma AA, Huisman MC. An automatic delineation method for bone marrow absorbed dose estimation in (89)Zr PET/CT studies. Ejnmmi Physics. 3: 13. PMID 27447823 DOI: 10.1186/S40658-016-0149-0  0.353
2016 van der Wildt B, Lammertsma AA, Drukarch B, Windhorst AD. Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography. Amino Acids. PMID 27380031 DOI: 10.1007/S00726-016-2288-Y  0.328
2016 Bahce I, Yaqub M, Smit EF, Lammertsma AA, van Dongen GA, Hendrikse NH. Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET. Lung Cancer (Amsterdam, Netherlands). PMID 27319335 DOI: 10.1016/J.Lungcan.2016.05.025  0.357
2016 Harms HJ, Huisman MC, Rijnierse MT, Greuter HN, Hsieh YL, de Haan S, Schuit RC, Knaapen P, Lubberink M, Lammertsma AA. Non-invasive quantification of myocardial [11C]-meta-hydroxyephedrine kinetics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27230922 DOI: 10.2967/Jnumed.115.167437  0.315
2016 Klein PJ, Chomet M, Metaxas A, Christiaans JA, Kooijman E, Schuit RC, Lammertsma AA, van Berckel BN, Windhorst AD. Synthesis, radiolabeling and evaluation of novel amine guanidine derivatives as potential positron emission tomography tracers for the ion channel of the N-methyl-d-aspartate receptor. European Journal of Medicinal Chemistry. 118: 143-160. PMID 27128179 DOI: 10.1016/J.Ejmech.2016.04.022  0.332
2016 Driessen RS, van Timmeren JE, Stuijfzand WJ, Rijnierse MT, Danad I, Raijmakers PG, Beek AM, van Rossum AC, Nijveldt R, Lammertsma AA, Harms HJ, Huisman MC, Knaapen P. Measurement of LV Volumes and Function Using Oxygen-15 Water-Gated PET and Comparison With CMR Imaging. Jacc. Cardiovascular Imaging. PMID 27085444 DOI: 10.1016/J.Jcmg.2016.01.014  0.403
2016 van der Wildt B, Wilhelmus MM, Bijkerk J, Haveman LY, Kooijman EJ, Schuit RC, Bol JG, Jongenelen CA, Lammertsma AA, Drukarch B, Windhorst AD. Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase. Nuclear Medicine and Biology. 43: 232-42. PMID 27067043 DOI: 10.1016/J.Nucmedbio.2016.01.003  0.363
2016 Heijtel DF, Petersen ET, Mutsaerts HJ, Bakker E, Schober P, Stevens MF, van Berckel BN, Majoie CB, Booij J, van Osch MJ, van Bavel ET, Boellaard R, Lammertsma AA, Nederveen AJ. Quantitative agreement between [(15) O]H2 O PET and model free QUASAR MRI-derived cerebral blood flow and arterial blood volume. Nmr in Biomedicine. PMID 26876426 DOI: 10.1002/Nbm.3480  0.415
2016 Bahce I, Yaqub M, Errami H, Schuit RC, Schober P, Thunnissen E, Windhorst AD, Lammertsma AA, Smit EF, Hendrikse NH. Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC. Ejnmmi Research. 6: 10. PMID 26857779 DOI: 10.1186/S13550-016-0169-8  0.31
2016 Timmer SA, Teunissen PF, Danad I, Robbers LF, Raijmakers PG, Nijveldt R, van Rossum AC, Lammertsma AA, van Royen N, Knaapen P. In vivo assessment of myocardial viability after acute myocardial infarction: A head-to-head comparison of the perfusable tissue index by PET and delayed contrast-enhanced CMR. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 26843199 DOI: 10.1007/S12350-015-0329-7  0.369
2016 Bruijnen S, Gent Y, Huisman M, Windhorst A, Kassiou M, Lammertsma A, Hoekstra O, Voskuyl A, Van der Laken C. SAT0558 New Generation Translocator Protein Pet Tracers To Image Arthritis by Macrophage Targeting in Rheumatoid Arthritis Patients: A Proof of Concept Study: Annals of the Rheumatic Diseases. 75: 871.2-871. DOI: 10.1136/Annrheumdis-2016-Eular.4215  0.387
2016 Verheijen R, Yaqub M, Sawicki E, van Tellingen O, Lammertsma A, Nuijen B, Schellens J, Beijnen J, Huitema A, Hendrikse N, Steeghs N. Molecular imaging of PgP/BCRP inhibition at the blood brain barrier using elacridar and [11C]erlotinib PET Annals of Oncology. 27: vi115. DOI: 10.1093/Annonc/Mdw368.06  0.372
2016 Driessen R, Stuijfzand W, Danad I, Raijmakers P, Min J, Leipsic J, Huisman M, Lammertsma A, van Rossum A, Van Royen N, Knaapen P. CT DERIVED ATHEROSCLEROTIC PLAQUE BURDEN AND MORPHOLOGY ARE ASSOCIATED WITH IMPAIRED MYOCARDIAL BLOOD FLOW USING [15O]H2O PET INDEPENDENT OF LUMINAL OBSTRUCTION Journal of the American College of Cardiology. 67: 1741. DOI: 10.1016/S0735-1097(16)31742-9  0.374
2016 Timmers T, Golla SSV, Ossenkoppele R, Groot C, Verfaillie SCJ, Scheltens P, Flier WMvd, Schober P, Schwarte LA, Mintun MA, Devous MD, Schuit RC, Windhorst AD, Lammertsma AA, Boellaard R, et al. Quantification Of Tau Load Using [18F]Av-1451 And Pet Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.227  0.329
2016 Wilde Ad, Flier WMvd, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, Berckel BNMv, Scheltens P. The Diagnostic Value Of Amyloid Pet In An Unselected Cohort Of Memory Clinic Patients Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.021  0.317
2015 Oprea-Lager DE, Kramer G, van de Ven P, van den Eertwegh A, van Moorselaar R, Schober P, Hoekstra OS, Lammertsma AA, Boellaard R. Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26697964 DOI: 10.2967/Jnumed.115.167692  0.363
2015 Froklage FE, Postnov A, Yaqub MM, Bakker E, Boellaard R, Hendrikse NH, Comans EF, Schuit RC, Schober P, Velis DN, Zwemmer J, Heimans JJ, Lammertsma AA, Voskuyl RA, Reijneveld JC. Altered GABAA receptor density and unaltered blood-brain barrier [11C]flumazenil transport in drug-resistant epilepsy patients with mesial temporal sclerosis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661244 DOI: 10.1177/0271678X15618219  0.313
2015 van der Doef TF, Golla SS, Klein PJ, Oropeza-Seguias GM, Schuit RC, Metaxas A, Jobse E, Schwarte LA, Windhorst AD, Lammertsma AA, van Berckel BN, Boellaard R. Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661185 DOI: 10.1177/0271678X15608391  0.344
2015 Iqbal R, Kramer GM, Verwer EE, Huisman MC, De Langen AJ, Bahce I, Van Velden FH, Windhorst AD, Lammertsma AA, Hoekstra OS, Boellaard R. Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26659349 DOI: 10.2967/Jnumed.115.166579  0.329
2015 Janssen B, Vugts DJ, Funke U, Molenaar GT, Kruijer PS, van Berckel BN, Lammertsma AA, Windhorst AD. Imaging of Neuroinflammation in Alzheimer's Disease, Multiple Sclerosis and Stroke: Recent Developments in Positron Emission Tomography. Biochimica Et Biophysica Acta. PMID 26643549 DOI: 10.1016/J.Bbadis.2015.11.011  0.353
2015 de Haan S, Rijnierse MT, Harms HJ, Verberne HJ, Lammertsma AA, Huisman MC, Windhorst AD, van Rossum AC, Allaart CP, Knaapen P. Myocardial denervation coincides with scar heterogeneity in ischemic cardiomyopathy: A PET and CMR study. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 26553060 DOI: 10.1007/S12350-015-0316-Z  0.357
2015 Verwer EE, Lammertsma AA, Boellaard R. Reply: Simplified Methods for Quantification of 18F-Fluoromethylcholine Uptake: Is SUVAUC,PP Actually an SUV? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1806-7. PMID 26429960 DOI: 10.2967/Jnumed.115.164087  0.307
2015 Adriaanse SM, Wink AM, Tijms BM, Ossenkoppele R, Verfaillie S, Lammertsma AA, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. The association of glucose metabolism and eigenvector centrality in Alzheimer's disease. Brain Connectivity. PMID 26414628 DOI: 10.1089/Brain.2014.0320  0.381
2015 Teunissen PF, Timmer SA, Danad I, de Waard GA, van de Ven PM, Raijmakers PG, Lammertsma AA, Van Rossum AC, van Royen N, Knaapen P. Coronary vasomotor function in infarcted and remote myocardium after primary percutaneous coronary intervention. Heart (British Cardiac Society). 101: 1577-83. PMID 26246402 DOI: 10.1136/Heartjnl-2015-307825  0.322
2015 Harms HJ, Lubberink M, de Haan S, Knaapen P, Huisman MC, Schuit RC, Windhorst AD, Allaart CP, Lammertsma AA. Use of a Single 11C-Meta-Hydroxyephedrine Scan for Assessing Flow-Innervation Mismatches in Patients with Ischemic Cardiomyopathy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1706-11. PMID 26229146 DOI: 10.2967/Jnumed.115.154377  0.334
2015 Mansor S, Boellaard R, Froklage FE, Bakker ED, Yaqub M, Voskuyl RA, Schwarte LA, Verbeek J, Windhorst AD, Lammertsma A. Quantification of Dynamic 11C-Phenytoin PET Studies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1372-7. PMID 26135114 DOI: 10.2967/Jnumed.115.158055  0.337
2015 Bakkum MJ, Danad I, Romijn MA, Stuijfzand WJ, Leonora RM, Tulevski II, Somsen GA, Lammertsma AA, van Kuijk C, van Rossum AC, Raijmakers PG, Knaapen P. The impact of obesity on the relationship between epicardial adipose tissue, left ventricular mass and coronary microvascular function. European Journal of Nuclear Medicine and Molecular Imaging. 42: 1562-73. PMID 26054890 DOI: 10.1007/S00259-015-3087-5  0.311
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669  0.332
2015 Verfaillie SC, Adriaanse SM, Binnewijzend MA, Benedictus MR, Ossenkoppele R, Wattjes MP, Pijnenburg YA, van der Flier WM, Lammertsma AA, Kuijer JP, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? European Radiology. PMID 25899416 DOI: 10.1007/S00330-015-3696-1  0.38
2015 Schmid S, Heijtel DF, Mutsaerts HJ, Boellaard R, Lammertsma AA, Nederveen AJ, van Osch MJ. Comparison of velocity- and acceleration-selective arterial spin labeling with [(15)O]H2O positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 25785831 DOI: 10.1038/Jcbfm.2015.42  0.384
2015 Teunissen PF, de Waard GA, Hollander MR, Robbers LF, Danad I, Biesbroek PS, Amier RP, Echavarría-Pinto M, Quirós A, Broyd C, Heymans MW, Nijveldt R, Lammertsma AA, Raijmakers PG, Allaart CP, et al. Doppler-derived intracoronary physiology indices predict the occurrence of microvascular injury and microvascular perfusion deficits after angiographically successful primary percutaneous coronary intervention. Circulation. Cardiovascular Interventions. 8: e001786. PMID 25717044 DOI: 10.1161/Circinterventions.114.001786  0.318
2015 Chandrupatla DM, Weijers K, Gent YY, de Greeuw I, Lammertsma AA, Jansen G, van der Laken CJ, Molthoff CF. Sustained macrophage infiltration upon multiple intra-articular injections: an improved rat model of rheumatoid arthritis for PET guided therapy evaluation. Biomed Research International. 2015: 509295. PMID 25695087 DOI: 10.1155/2015/509295  0.332
2015 Oprea-Lager DE, Yaqub M, Pieters IC, Reinhard R, van Moorselaar RJ, van den Eertwegh AJ, Hoekstra OS, Lammertsma AA, Boellaard R. A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 25690949 DOI: 10.1007/S11307-015-0826-8  0.393
2015 Golla SS, Boellaard R, Oikonen V, Hoffmann A, van Berckel BN, Windhorst AD, Virta J, Haaparanta-Solin M, Luoto P, Savisto N, Solin O, Valencia R, Thiele A, Eriksson J, Schuit RC, ... Lammertsma AA, et al. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 766-72. PMID 25649991 DOI: 10.1038/Jcbfm.2014.261  0.375
2015 Klein PJ, Christiaans JA, Metaxas A, Schuit RC, Lammertsma AA, van Berckel BN, Windhorst AD. Synthesis, structure activity relationship, radiolabeling and preclinical evaluation of high affinity ligands for the ion channel of the N-methyl-d-aspartate receptor as potential imaging probes for positron emission tomography. Bioorganic & Medicinal Chemistry. 23: 1189-206. PMID 25648682 DOI: 10.1016/J.Bmc.2014.12.029  0.375
2015 Klumpers UM, Veltman DJ, van Tol MJ, Kloet RW, Boellaard R, Lammertsma AA, Hoogendijk WJ. Neurophysiological effects of sleep deprivation in healthy adults, a pilot study. Plos One. 10: e0116906. PMID 25608023 DOI: 10.1371/Journal.Pone.0116906  0.685
2015 Stuijfzand WJ, Uusitalo V, Kero T, Danad I, Rijnierse MT, Saraste A, Raijmakers PG, Lammertsma AA, Harms HJ, Heymans MW, Huisman MC, Marques KM, Kajander SA, Pietilä M, Sörensen J, et al. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease. Circulation. Cardiovascular Imaging. 8. PMID 25596142 DOI: 10.1161/Circimaging.114.002400  0.324
2015 Hacker M, Beyer T, Baum RP, Kalemis A, Lammertsma AA, Lewington V, Talbot JN, Verzijlbergen F. Nuclear medicine innovations help (drive) healthcare (benefits). European Journal of Nuclear Medicine and Molecular Imaging. 42: 173-5. PMID 25416634 DOI: 10.1007/S00259-014-2957-6  0.346
2015 Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 472-9. PMID 25248987 DOI: 10.1038/Npp.2014.195  0.348
2015 Mammatas LH, Verheul HM, Hendrikse NH, Yaqub M, Lammertsma AA, Menke-van der Houven van Oordt CW. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care. Cellular Oncology (Dordrecht). 38: 49-64. PMID 25248503 DOI: 10.1007/S13402-014-0194-4  0.381
2015 van Velden FH, Mansor SM, van Assema DM, van Berckel BN, Froklage FE, Wang S, Schuit RC, Asselin MC, Lammertsma AA, Boellaard R, Huisman MC. Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 129-39. PMID 25028091 DOI: 10.1007/S11307-014-0766-8  0.382
2015 van der Laken C, Chandrupatla D, Molthoff C, Jansen G, Greeuw I, Verlaan M, van Kooij R, Bloemendaal M, Windhorst B, Lammertsma A, Low P, Qingshou C. AB0116 In Vivo Evaluation of Folate Receptor Expression in Relation to Methotrexate Treatment Efficacy in Arthritic Rats Using [18F]-PEG-Folate PET Annals of the Rheumatic Diseases. 74: 929.2-929. DOI: 10.1136/Annrheumdis-2015-Eular.5451  0.353
2014 Harms HJ, de Haan S, Knaapen P, Allaart CP, Rijnierse MT, Schuit RC, Windhorst AD, Lammertsma AA, Huisman MC, Lubberink M. Quantification of [(11)C]-meta-hydroxyephedrine uptake in human myocardium. Ejnmmi Research. 4: 52. PMID 26116116 DOI: 10.1186/S13550-014-0052-4  0.341
2014 Verwer EE, Bahce I, van Velden FH, Yaqub M, Schuit RC, Windhorst AD, Raijmakers P, Hoekstra OS, Lammertsma AA, Smit EF, Boellaard R. Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1772-7. PMID 25324522 DOI: 10.2967/Jnumed.114.141846  0.345
2014 Makris NE, van Velden FH, Huisman MC, Menke CW, Lammertsma AA, Boellaard R. Validation of simplified dosimetry approaches in ⁸⁹Zr-PET/CT: the use of manual versus semi-automatic delineation methods to estimate organ absorbed doses. Medical Physics. 41: 102503. PMID 25281978 DOI: 10.1118/1.4895973  0.375
2014 Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, Heymans MW, Kajander SA, Pietilä M, James S, Sörensen J, Knaapen P, Knuuti J. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. Journal of the American College of Cardiology. 64: 1464-75. PMID 25277618 DOI: 10.1016/J.Jacc.2014.05.069  0.345
2014 Lammertsma AA, Sawle GV, Frackowiak RS. Ageing and brain: clinical perspectives of PET. Technology and Health Care : Official Journal of the European Society For Engineering and Medicine. 1: 11-7. PMID 25273005 DOI: 10.3233/Thc-1993-1103  0.326
2014 Janssen B, Vugts DJ, Funke U, Spaans A, Schuit RC, Kooijman E, Rongen M, Perk LR, Lammertsma AA, Windhorst AD. Synthesis and initial preclinical evaluation of the P2X7 receptor antagonist [¹¹C]A-740003 as a novel tracer of neuroinflammation. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 509-16. PMID 24995673 DOI: 10.1002/Jlcr.3206  0.346
2014 Frings V, Yaqub M, Hoyng LL, Golla SS, Windhorst AD, Schuit RC, Lammertsma AA, Hoekstra OS, Smit EF, Boellaard R. Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1417-23. PMID 24970910 DOI: 10.2967/Jnumed.114.140913  0.392
2014 Christiaans JA, Klein PJ, Metaxas A, Kooijman EJ, Schuit RC, Leysen JE, Lammertsma AA, van Berckel BN, Windhorst AD. Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[(11)C]methoxyphenyl)pyridin-3-yl)methyl)cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors. Nuclear Medicine and Biology. 41: 670-80. PMID 24929961 DOI: 10.1016/J.Nucmedbio.2014.04.131  0.306
2014 Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Comparison of simplified parametric methods for visual interpretation of 11C-Pittsburgh compound-B PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1305-7. PMID 24898026 DOI: 10.2967/Jnumed.114.139121  0.347
2014 Bogdanović RM, Syvänen S, Michler C, Russmann V, Eriksson J, Windhorst AD, Lammertsma AA, de Lange EC, Voskuyl RA, Potschka H. (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology. 85: 104-12. PMID 24880085 DOI: 10.1016/J.Neuropharm.2014.05.002  0.313
2014 van der Veldt AA, Lammertsma AA. In vivo imaging as a pharmacodynamic marker. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2569-77. PMID 24831279 DOI: 10.1158/1078-0432.Ccr-13-2666  0.349
2014 Danad I, Raijmakers PG, Harms HJ, Heymans MW, van Royen N, Lubberink M, Boellaard R, van Rossum AC, Lammertsma AA, Knaapen P. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study. European Heart Journal. 35: 2094-105. PMID 24780500 DOI: 10.1093/Eurheartj/Ehu170  0.4
2014 Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, et al. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. Neurology. 82: 1768-75. PMID 24748672 DOI: 10.1212/Wnl.0000000000000432  0.34
2014 Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, van Berckel B, van der Flier W. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. Journal of Alzheimer's Disease : Jad. 41: 801-7. PMID 24705549 DOI: 10.3233/Jad-132561  0.344
2014 Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Kassiou M, Jansen G, Lammertsma AA, van der Laken CJ. Promising potential of new generation translocator protein tracers providing enhanced contrast of arthritis imaging by positron emission tomography in a rat model of arthritis. Arthritis Research & Therapy. 16: R70. PMID 24625077 DOI: 10.1186/Ar4509  0.342
2014 Heijtel DF, Mutsaerts HJ, Bakker E, Schober P, Stevens MF, Petersen ET, van Berckel BN, Majoie CB, Booij J, van Osch MJ, Vanbavel E, Boellaard R, Lammertsma AA, Nederveen AJ. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with ¹⁵O Hâ‚‚O positron emission tomography. Neuroimage. 92: 182-92. PMID 24531046 DOI: 10.1016/J.Neuroimage.2014.02.011  0.408
2014 Boellaard R, Hofman MB, Hoekstra OS, Lammertsma AA. Accurate PET/MR quantification using time of flight MLAA image reconstruction. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 469-77. PMID 24430291 DOI: 10.1007/S11307-013-0716-X  0.379
2014 Makris NE, Boellaard R, Visser EP, de Jong JR, Vanderlinden B, Wierts R, van der Veen BJ, Greuter HJ, Vugts DJ, van Dongen GA, Lammertsma AA, Huisman MC. Multicenter harmonization of 89Zr PET/CT performance. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 264-7. PMID 24357686 DOI: 10.2967/Jnumed.113.130112  0.376
2014 Rijnierse MT, de Haan S, Harms HJ, Robbers LF, Wu L, Danad I, Beek AM, Heymans MW, van Rossum AC, Lammertsma AA, Allaart CP, Knaapen P. Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy. Circulation. Cardiovascular Imaging. 7: 20-30. PMID 24343851 DOI: 10.1161/CIRCIMAGING.113.001158  0.354
2014 van Golen LW, Kuijer JP, Huisman MC, IJzerman RG, Barkhof F, Diamant M, Lammertsma AA. Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET). Journal of Magnetic Resonance Imaging : Jmri. 40: 1300-9. PMID 24214919 DOI: 10.1002/Jmri.24484  0.399
2014 Chen WJ, Danad I, Raijmakers PG, Halbmeijer R, Harms HJ, Lammertsma AA, van Rossum AC, Diamant M, Knaapen P. Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function. The American Journal of Cardiology. 113: 90-7. PMID 24169015 DOI: 10.1016/J.Amjcard.2013.09.022  0.303
2014 Harms HJ, Nesterov SV, Han C, Danad I, Leonora R, Raijmakers PG, Lammertsma AA, Knuuti J, Knaapen P. Comparison of clinical non-commercial tools for automated quantification of myocardial blood flow using oxygen-15-labelled water PET/CT. European Heart Journal Cardiovascular Imaging. 15: 431-41. PMID 24107905 DOI: 10.1093/Ehjci/Jet177  0.406
2014 Danad I, Raijmakers PG, Harms HJ, van Kuijk C, van Royen N, Diamant M, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Effect of cardiac hybrid ¹⁵O-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate. European Heart Journal Cardiovascular Imaging. 15: 170-9. PMID 23839653 DOI: 10.1093/Ehjci/Jet125  0.389
2014 van Velden FH, Nissen IA, Jongsma F, Velasquez LM, Hayes W, Lammertsma AA, Hoekstra OS, Boellaard R. Test-retest variability of various quantitative measures to characterize tracer uptake and/or tracer uptake heterogeneity in metastasized liver for patients with colorectal carcinoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 13-8. PMID 23807457 DOI: 10.1007/S11307-013-0660-9  0.365
2014 Scheffler M, Bos MCA, Sos ML, Heukamp LC, Nogova L, Koenig K, Gardizi M, Mattonet C, Kahraman D, Kobe C, Boellaard R, Lammertsma AA, Persigehl T, Engel-Riedel W, Toepelt K, et al. MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET, DCE-MRI and molecular biomarkers for early prediction of nonprogression in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. Journal of Clinical Oncology. 32: e19049-e19049. DOI: 10.1200/Jco.2014.32.15_Suppl.E19049  0.374
2014 Doef TFvd, Golla SVS, Klein PJ, Schuit RC, Windhorst BD, Lammertsma AA, Berckel BNMv, Boellaard R. Poster #T243 [11C]GMOM AS NEW POTENTIAL PET RADIOTRACER TO IMAGE THE NMDA RECEPTOR IN VIVO Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)71059-X  0.336
2014 de Waard G, Danad I, da Cunha RP, Teunissen P, van de Hoef T, Raijmakers P, Lammertsma A, Davies J, Knaapen P, Van Royen N. HYPEREMIC FFR AND BASELINE IFR HAVE AN EQUIVALENT DIAGNOSTIC ACCURACY WHEN COMPARED TO MYOCARDIAL BLOOD FLOW QUANTIFIED BY H215O PET PERFUSION IMAGING Journal of the American College of Cardiology. 63: A1692. DOI: 10.1016/S0735-1097(14)61695-8  0.396
2014 Stuijfzand W, Uusitalo V, Kero T, Danad I, Saraste A, Raijmakers P, Lammertsma A, Marques K, Kajander S, Pietila M, Sorensen J, Van Royen N, Knuuti J, Knaapen P. NONINVASIVE FRACTIONAL FLOW RESERVE DERIVED FROM QUANTITATIVE PERFUSION POSITRON EMISSION TOMOGRAPHY Journal of the American College of Cardiology. 63: A1009. DOI: 10.1016/S0735-1097(14)61009-3  0.367
2014 Lammertsma AA, Boellaard R. The need for quantitative PET in multicentre studies Clinical and Translational Imaging. 2: 277-280. DOI: 10.1007/S40336-014-0074-Y  0.416
2013 Ruiter G, Wong YY, Raijmakers P, Huisman MC, Lammertsma AA, Knaapen P, de Man FS, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A. Pulmonary 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake is low in treated patients with idiopathic pulmonary arterial hypertension. Pulmonary Circulation. 3: 647-53. PMID 24618549 DOI: 10.1086/674335  0.362
2013 Persoon S, van Berckel BN, Bremmer JP, Boellaard R, Algra A, de Borst GJ, Lammertsma AA, Kappelle LJ, Klijn CJ. Intervention versus standard medical treatment in patients with symptomatic occlusion of the internal carotid artery: a randomised oxygen-15 PET study. Ejnmmi Research. 3: 79. PMID 24308868 DOI: 10.1186/2191-219X-3-79  0.354
2013 Funke U, Vugts DJ, Janssen B, Spaans A, Kruijer PS, Lammertsma AA, Perk LR, Windhorst AD. (11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain. Journal of Labelled Compounds & Radiopharmaceuticals. 56: 120-9. PMID 24285318 DOI: 10.1002/Jlcr.3038  0.343
2013 Chen WJ, Greulich S, van der Meer RW, Rijzewijk LJ, Lamb HJ, de Roos A, Smit JW, Romijn JA, Ruige JB, Lammertsma AA, Lubberink M, Diamant M, Ouwens DM. Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes. Cardiovascular Diabetology. 12: 150. PMID 24134550 DOI: 10.1186/1475-2840-12-150  0.303
2013 Postnov A, Froklage FE, van Lingen A, Reijneveld JC, Hendrikse NH, Windhorst AD, Schuit RC, Eriksson J, Lammertsma AA, Huisman MC. Radiation dose of the P-glycoprotein tracer 11C-laniquidar. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 2101-3. PMID 24092938 DOI: 10.2967/Jnumed.113.120857  0.383
2013 van der Veldt AA, Smit EF, Lammertsma AA. Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [(11)C]docetaxel. Frontiers in Oncology. 3: 208. PMID 23986880 DOI: 10.3389/Fonc.2013.00208  0.304
2013 Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1423-31. PMID 23876376 DOI: 10.1016/J.Euroneuro.2013.05.012  0.576
2013 Zanotti-Fregonara P, Lammertsma AA, Innis RB. Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1781-3. PMID 23868334 DOI: 10.1007/S00259-013-2512-X  0.308
2013 Syvänen S, Russmann V, Verbeek J, Eriksson J, Labots M, Zellinger C, Seeger N, Schuit R, Rongen M, van Kooij R, Windhorst AD, Lammertsma AA, de Lange EC, Voskuyl RA, Koepp M, et al. [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness. Nuclear Medicine and Biology. 40: 764-75. PMID 23827307 DOI: 10.1016/J.Nucmedbio.2013.05.008  0.336
2013 Makris NE, Huisman MC, Kinahan PE, Lammertsma AA, Boellaard R. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1507-15. PMID 23754762 DOI: 10.1007/S00259-013-2465-0  0.384
2013 Verwer EE, van Velden FH, Bahce I, Yaqub M, Schuit RC, Windhorst AD, Raijmakers P, Lammertsma AA, Smit EF, Boellaard R. Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 40: 1523-31. PMID 23740374 DOI: 10.1007/S00259-013-2462-3  0.387
2013 Wong YY, Raijmakers P, van Campen J, van der Laarse WJ, Knaapen P, Lubberink M, Ruiter G, Vonk Noordegraaf A, Lammertsma AA. 11C-Acetate clearance as an index of oxygen consumption of the right myocardium in idiopathic pulmonary arterial hypertension: a validation study using 15O-labeled tracers and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1258-62. PMID 23735834 DOI: 10.2967/Jnumed.112.115915  0.363
2013 van der Veldt AA, Lubberink M, Mathijssen RH, Loos WJ, Herder GJ, Greuter HN, Comans EF, Rutten HB, Eriksson J, Windhorst AD, Hendrikse NH, Postmus PE, Smit EF, Lammertsma AA. Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4163-73. PMID 23620410 DOI: 10.1158/1078-0432.Ccr-12-3779  0.372
2013 Buiter HJ, Windhorst AD, Huisman MC, De Maeyer JH, Schuurkes JA, Lammertsma AA, Leysen JE. Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor. Ejnmmi Research. 3: 24. PMID 23557209 DOI: 10.1186/2191-219X-3-24  0.352
2013 van Golen LW, Huisman MC, Ijzerman RG, Hoetjes NJ, Schwarte LA, Lammertsma AA, Diamant M. Cerebral blood flow and glucose metabolism measured with positron emission tomography are decreased in human type 1 diabetes. Diabetes. 62: 2898-904. PMID 23530004 DOI: 10.2337/Db12-1159  0.323
2013 Buiter HJ, Windhorst AD, Huisman MC, Yaqub M, Knol DL, Fisher A, Lammertsma AA, Leysen JE. [11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors. Ejnmmi Research. 3: 19. PMID 23514539 DOI: 10.1186/2191-219X-3-19  0.35
2013 Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, Kularatne SA, Jansen G, Low PS, Lammertsma AA, van der Laken CJ. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Research & Therapy. 15: R37. PMID 23452511 DOI: 10.1186/Ar4191  0.379
2013 Varrone A, Mattsson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, Al-Tawil N, Eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, et al. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. European Journal of Nuclear Medicine and Molecular Imaging. 40: 921-31. PMID 23436070 DOI: 10.1007/S00259-013-2359-1  0.392
2013 Scheffler M, Zander T, Nogova L, Kobe C, Kahraman D, Dietlein M, Papachristou I, Heukamp L, Büttner R, Boellaard R, Lammertsma AA, Querings S, Stoelben E, Engel-Riedel W, Neumaier B, et al. Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib. Plos One. 8: e53081. PMID 23308140 DOI: 10.1371/Journal.Pone.0053081  0.371
2013 Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80: 359-65. PMID 23255822 DOI: 10.1212/Wnl.0B013E31827F0889  0.369
2013 Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, Heymans MW, Tulevski II, van Kuijk C, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 55-63. PMID 23232274 DOI: 10.2967/Jnumed.112.104687  0.402
2013 de Vries FE, van den Heuvel OA, Cath DC, Groenewegen HJ, van Balkom AJ, Boellaard R, Lammertsma AA, Veltman DJ. Limbic and motor circuits involved in symmetry behavior in Tourette's syndrome. Cns Spectrums. 18: 34-42. PMID 23199522 DOI: 10.1017/S1092852912000703  0.581
2013 Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, Windhorst AD, Handels RL, Wolfs CA, Aalten P, Verhey FR, Verbeek MM, van Buchem MA, Hoekstra OS, Lammertsma AA, et al. Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 414-21. PMID 23164552 DOI: 10.1016/J.Jalz.2012.07.003  0.397
2013 Bahce I, Smit EF, Lubberink M, van der Veldt AA, Yaqub M, Windhorst AD, Schuit RC, Thunnissen E, Heideman DA, Postmus PE, Lammertsma AA, Hendrikse NH. Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 183-93. PMID 23136193 DOI: 10.1158/1078-0432.Ccr-12-0289  0.332
2013 Schuitemaker A, Kropholler MA, Boellaard R, van der Flier WM, Kloet RW, van der Doef TF, Knol DL, Windhorst AD, Luurtsema G, Barkhof F, Jonker C, Lammertsma AA, Scheltens P, van Berckel BN. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Neurobiology of Aging. 34: 128-36. PMID 22840559 DOI: 10.1016/J.Neurobiolaging.2012.04.021  0.348
2013 Gent Y, Weijers K, Molthoff C, Windhorst A, de Greeuw I, Al M, Bergstra R, Verlaan M, Kassiou M, Lammertsma A, Jansen G, van der Laken C. OP0235 Pet high affinity translocator protein ligands as a novel modality for macrophage targeting in arthritis Annals of the Rheumatic Diseases. 71: 135.2-135. DOI: 10.1136/Annrheumdis-2012-Eular.1918  0.369
2013 De Haan S, Rijnierse MT, Harms HJ, Allaart CP, Huisman M, Van Rossum AC, Lammertsma AA, Knaapen P. PET/CT assessed myocardial innervation and perfusion mismatch correlates with heterogenic scar size assessed with CMR European Heart Journal. 34: P1871-P1871. DOI: 10.1093/Eurheartj/Eht308.P1871  0.364
2013 Rijnierse MT, Allaart CP, De Haan S, Harms HJ, Wu L, Danad I, Van Rossum AC, Lammertsma AA, Knaapen P. Inducibility of ventricular arrhythmias is related with impaired hyperaemic myocardial blood flow assessed with [15O]H2O PET in patients with ischaemic cardiomyopathy European Heart Journal. 34: P1870-P1870. DOI: 10.1093/Eurheartj/Eht308.P1870  0.352
2013 Danad I, Raijmakers PG, Harms HJ, Kuijk Cv, Royen Nv, Diamant M, Lammertsma AA, Lubberink M, Rossum ACv, Knaapen P. Effect Of Cardiac Hybrid 150-Water Pet/Ct Imaging Upon Downstream Referral For Invasive Coronary Angiography And Revascularization Rate Journal of the American College of Cardiology. 61. DOI: 10.1016/S0735-1097(13)60841-4  0.358
2013 Danad I, Raijmakers PG, Harms HJ, van Royen N, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. QUANTITATIVE RELATIONSHIP BETWEEN THE ANATOMICAL AND FUNCTIONAL SEVERITY OF CORONARY ATHEROSCLEROTIC PLAQUES AND TRANSMURAL MYOCARDIAL BLOOD FLOW GRADIENT: A H2150 PET STUDY Journal of the American College of Cardiology. 61: E832. DOI: 10.1016/S0735-1097(13)60832-3  0.356
2013 Zwan M, Harten Av, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, Berckel BNMv, Flier WVd. Concordance between CSF biomarkers and [11C]PiB-PET in a memory clinic population Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.008  0.308
2013 Berckel Bv, Goos J, Assema DME, Kloet R, Yaqub M, Bakker E, Scheltens P, Barkhof F, Lammertsma A, Flier WVd, Boellaard R. Cerebral amyloid angiopathy in Alzheimer’s disease is associated with increased blood-brain barrier permeability: A quantitative [11C]PiB-PET study Alzheimers & Dementia. 9: 130. DOI: 10.1016/J.Jalz.2013.05.006  0.376
2012 Huisman MC, van Golen LW, Hoetjes NJ, Greuter HN, Schober P, Ijzerman RG, Diamant M, Lammertsma AA. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. Ejnmmi Research. 2: 63. PMID 23168248 DOI: 10.1186/2191-219X-2-63  0.437
2012 Syvänen S, Labots M, Tagawa Y, Eriksson J, Windhorst AD, Lammertsma AA, de Lange EC, Voskuyl RA. Altered GABAA receptor density and unaltered blood-brain barrier transport in a kainate model of epilepsy: an in vivo study using 11C-flumazenil and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1974-83. PMID 23143088 DOI: 10.2967/Jnumed.112.104588  0.334
2012 van Assema DM, Lubberink M, Rizzu P, van Swieten JC, Schuit RC, Eriksson J, Scheltens P, Koepp M, Lammertsma AA, van Berckel BN. Blood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene. Ejnmmi Research. 2: 57. PMID 23067778 DOI: 10.1186/2191-219X-2-57  0.372
2012 Buiter HJ, van Velden FH, Leysen JE, Fisher A, Windhorst AD, Lammertsma AA, Huisman MC. Reproducible Analysis of Rat Brain PET Studies Using an Additional [(18)F]NaF Scan and an MR-Based ROI Template. International Journal of Molecular Imaging. 2012: 580717. PMID 23050141 DOI: 10.1155/2012/580717  0.411
2012 Cheebsumon P, Boellaard R, de Ruysscher D, van Elmpt W, van Baardwijk A, Yaqub M, Hoekstra OS, Comans EF, Lammertsma AA, van Velden FH. Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology. Ejnmmi Research. 2: 56. PMID 23034289 DOI: 10.1186/2191-219X-2-56  0.394
2012 Kahraman D, Holstein A, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Dietlein M, Wolf J, Kobe C. Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib. Clinical Nuclear Medicine. 37: 1058-64. PMID 23027207 DOI: 10.1097/Rlu.0B013E3182639747  0.347
2012 Verbeek J, Eriksson J, Syvänen S, Labots M, de Lange EC, Voskuyl RA, Mooijer MP, Rongen M, Lammertsma AA, Windhorst AD. [11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats. Ejnmmi Research. 2: 36. PMID 22747744 DOI: 10.1186/2191-219X-2-36  0.334
2012 Persoon S, Kappelle LJ, van Berckel BN, Boellaard R, Ferrier CH, Lammertsma AA, Klijn CJ. Comparison of oxygen-15 PET and transcranial Doppler CO2-reactivity measurements in identifying haemodynamic compromise in patients with symptomatic occlusion of the internal carotid artery. Ejnmmi Research. 2: 30. PMID 22682265 DOI: 10.1186/2191-219X-2-30  0.398
2012 van Assema DM, Goos JD, van der Flier WM, Lubberink M, Boellaard R, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1468-71. PMID 22588188 DOI: 10.1038/Jcbfm.2012.64  0.393
2012 Yaqub M, van Berckel BN, Schuitemaker A, Hinz R, Turkheimer FE, Tomasi G, Lammertsma AA, Boellaard R. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1600-8. PMID 22588187 DOI: 10.1038/Jcbfm.2012.59  0.379
2012 de Haan S, Harms HJ, Lubberink M, Allaart CP, Danad I, Chen WJ, Diamant M, van Rossum AC, Iida H, Lammertsma AA, Knaapen P. Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1240-5. PMID 22576999 DOI: 10.1007/S00259-012-2134-8  0.375
2012 Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain : a Journal of Neurology. 135: 2115-25. PMID 22556189 DOI: 10.1093/Brain/Aws113  0.356
2012 Kobe C, Scheffler M, Holstein A, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Dietlein M, Wolf J, Kahraman D. Predictive value of early and late residual 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib. European Journal of Nuclear Medicine and Molecular Imaging. 39: 1117-27. PMID 22526960 DOI: 10.1007/S00259-012-2118-8  0.368
2012 van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. P-glycoprotein function at the blood-brain barrier: effects of age and gender. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 771-6. PMID 22476967 DOI: 10.1007/S11307-012-0556-0  0.307
2012 Froklage FE, Syvänen S, Hendrikse NH, Huisman MC, Molthoff CF, Tagawa Y, Reijneveld JC, Heimans JJ, Lammertsma AA, Eriksson J, de Lange EC, Voskuyl RA. [11C]Flumazenil brain uptake is influenced by the blood-brain barrier efflux transporter P-glycoprotein. Ejnmmi Research. 2: 12. PMID 22455873 DOI: 10.1186/2191-219X-2-12  0.336
2012 Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. 39: 990-1000. PMID 22441582 DOI: 10.1007/S00259-012-2102-3  0.385
2012 van Velden FH, van Beers P, Nuyts J, Velasquez LM, Hayes W, Lammertsma AA, Boellaard R, Loeckx D. Effects of rigid and non-rigid image registration on test-retest variability of quantitative [18F]FDG PET/CT studies. Ejnmmi Research. 2: 10. PMID 22404895 DOI: 10.1186/2191-219X-2-10  0.426
2012 Lubberink M, Direcks W, Emmering J, van Tinteren H, Hoekstra OS, van der Hoeven JJ, Molthoff CF, Lammertsma AA. Validity of simplified 3'-deoxy-3'-[18F]fluorothymidine uptake measures for monitoring response to chemotherapy in locally advanced breast cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 777-82. PMID 22392642 DOI: 10.1007/S11307-012-0547-1  0.344
2012 Danad I, Raijmakers PG, Kamali P, Harms HJ, de Haan S, Lubberink M, van Kuijk C, Hoekstra OS, Lammertsma AA, Smulders YM, Heymans MW, Tulevski II, van Rossum AC, Knaapen P. Carotid artery intima-media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease. European Heart Journal Cardiovascular Imaging. 13: 317-23. PMID 22379124 DOI: 10.1093/Eurheartj/Ehs284  0.321
2012 Klumpers UM, Boellaard R, Veltman DJ, Kloet RW, Hoogendijk WJ, Lammertsma AA. Parametric [11C]flumazenil images. Nuclear Medicine Communications. 33: 422-30. PMID 22293497 DOI: 10.1097/Mnm.0B013E3283505F7B  0.626
2012 van Assema DM, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, van Berckel BN, Lammertsma AA. Reproducibility of quantitative (R)-[11C]verapamil studies. Ejnmmi Research. 2: 1. PMID 22251281 DOI: 10.1186/2191-219X-2-1  0.339
2012 Verbeek J, Syvänen S, Schuit RC, Eriksson J, de Lange EC, Windhorst AD, Luurtsema G, Lammertsma AA. Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil. Nuclear Medicine and Biology. 39: 530-9. PMID 22226023 DOI: 10.1016/J.Nucmedbio.2011.10.017  0.332
2012 van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD, Comans EF, Hoetjes NJ, Tolboom N, Langer O, Müller M, Scheltens P, Lammertsma AA, van Berckel BN. Blood-brain barrier P-glycoprotein function in Alzheimer's disease. Brain : a Journal of Neurology. 135: 181-9. PMID 22120145 DOI: 10.1016/J.Jalz.2011.05.275  0.34
2012 Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, Marques KM, van Kuijk C, Allaart CP, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 19: 256-64. PMID 22076826 DOI: 10.1007/S12350-011-9476-7  0.353
2012 Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML, van Kuijk C, Allaart CP, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study. European Journal of Nuclear Medicine and Molecular Imaging. 39: 102-12. PMID 22005845 DOI: 10.1007/S00259-011-1956-0  0.386
2012 Gent YY, Voskuyl AE, Kloet RW, van Schaardenburg D, Hoekstra OS, Dijkmans BA, Lammertsma AA, van der Laken CJ. Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study. Arthritis and Rheumatism. 64: 62-6. PMID 21898356 DOI: 10.1002/Art.30655  0.384
2012 Schuitemaker A, van der Doef TF, Boellaard R, van der Flier WM, Yaqub M, Windhorst AD, Barkhof F, Jonker C, Kloet RW, Lammertsma AA, Scheltens P, van Berckel BN. Microglial activation in healthy aging. Neurobiology of Aging. 33: 1067-72. PMID 21051106 DOI: 10.1016/J.Neuroimage.2010.04.215  0.314
2012 Scheffler M, Bos MCA, Sos M, Nogova L, Mattonet C, Papachristou I, Kahraman D, Kobe C, Boellaard R, Lammertsma AA, Heukamp LC, Büttner R, Elter T, Toepelt K, Engel-Riedel W, et al. MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET and DCE-MRI for early prediction of efficacy in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. Journal of Clinical Oncology. 30: 7603-7603. DOI: 10.1200/Jco.2012.30.15_Suppl.7603  0.387
2012 Danad I, Raijmakers PG, Appelman Y, Harms H, Lubberink M, Tulevski I, Lammertsma AA, van Rossum A, Knaapen P. DIAGNOSTIC ACCURACY OF QUANTITATIVE H215O PET MEASUREMENTS OF HYPEREMIC MYOCARDIAL BLOOD FLOW VERSUS CORONARY FLOW RESERVE FOR THE DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE Journal of the American College of Cardiology. 59: E1312. DOI: 10.1016/S0735-1097(12)61313-8  0.326
2012 Buiter HJC, Leysen JE, Schuit RC, Fisher A, Lammertsma AA, Windhorst AD. Radiosynthesis and biological evaluation of the M1 muscarinic acetylcholine receptor agonist ligand [11C]AF150(S) Journal of Labelled Compounds and Radiopharmaceuticals. 55: 264-273. DOI: 10.1002/Jlcr.2932  0.346
2011 Cheebsumon P, van Velden FH, Yaqub M, Hoekstra CJ, Velasquez LM, Hayes W, Hoekstra OS, Lammertsma AA, Boellaard R. Measurement of metabolic tumor volume: static versus dynamic FDG scans. Ejnmmi Research. 1: 35. PMID 22214394 DOI: 10.1186/2191-219X-1-35  0.352
2011 Kahraman D, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Holstein A, Dietlein M, Wolf J, Kobe C. Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1871-7. PMID 22065872 DOI: 10.2967/Jnumed.111.094458  0.378
2011 Bondarenko O, Knaapen P, Beek AM, Boellaard R, Lammertsma AA, van Rossum AC. Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study. Nuclear Medicine Communications. 32: 1169-73. PMID 22045477 DOI: 10.1097/Mnm.0B013E32834Bfe51  0.374
2011 Timmer SA, Germans T, Brouwer WP, Lubberink M, van der Velden J, Wilde AA, Christiaans I, Lammertsma AA, Knaapen P, van Rossum AC. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction. European Journal of Heart Failure. 13: 1283-9. PMID 22021246 DOI: 10.1093/Eurjhf/Hfr135  0.351
2011 Timmer SA, Knaapen P, Germans T, Lubberink M, Dijkmans PA, Vonk-Noordegraaf A, Ten Berg JM, Ten Cate FJ, Lammertsma AA, van Rossum AC. Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation. Journal of Cardiac Failure. 17: 827-31. PMID 21962421 DOI: 10.1016/J.Cardfail.2011.06.375  0.317
2011 Wolfensberger SP, Maruyama K, van Berckel BN, Lubberink M, Airaksinen AJ, Boellaard R, Luurtsema G, Reddingius W, Janssens FE, Veltman DJ, Windhorst AD, Leysen JE, Lammertsma AA. Quantification of the neurokinin 1 receptor ligand [¹¹C]R116301. Nuclear Medicine Communications. 32: 896-902. PMID 21876400 DOI: 10.1097/Mnm.0B013E328347E96F  0.621
2011 Cheebsumon P, Yaqub M, van Velden FH, Hoekstra OS, Lammertsma AA, Boellaard R. Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology. European Journal of Nuclear Medicine and Molecular Imaging. 38: 2136-44. PMID 21858528 DOI: 10.1007/S00259-011-1899-5  0.336
2011 Cheebsumon P, van Velden FH, Yaqub M, Frings V, de Langen AJ, Hoekstra OS, Lammertsma AA, Boellaard R. Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1550-8. PMID 21849398 DOI: 10.2967/Jnumed.111.088914  0.345
2011 Chen WJ, Rijzewijk LJ, van der Meer RW, Heymans MW, van Duinkerken E, Lubberink M, Lammertsma AA, Lamb HJ, de Roos A, Romijn JA, Smit JW, Bax JJ, Bjerre M, Frystyk J, Flyvbjerg A, et al. Association of plasma osteoprotegerin and adiponectin with arterial function, cardiac function and metabolism in asymptomatic type 2 diabetic men. Cardiovascular Diabetology. 10: 67. PMID 21771299 DOI: 10.1186/1475-2840-10-67  0.318
2011 Folkersma H, Boellaard R, Yaqub M, Kloet RW, Windhorst AD, Lammertsma AA, Vandertop WP, van Berckel BN. Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1235-9. PMID 21764792 DOI: 10.2967/Jnumed.110.084061  0.313
2011 van der Veldt AA, Lubberink M, Greuter HN, Comans EF, Herder GJ, Yaqub M, Schuit RC, van Lingen A, Rizvi SN, Mooijer MP, Rijnders AY, Windhorst AD, Smit EF, Hendrikse NH, Lammertsma AA. Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4814-24. PMID 21750197 DOI: 10.1158/1078-0432.Ccr-10-2933  0.358
2011 van der Veldt AA, Lubberink M, Lammertsma AA, Smit EF. Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction. European Radiology. 21: 2148-9; author reply. PMID 21681575 DOI: 10.1007/S00330-011-2172-9  0.357
2011 Folkersma H, Foster Dingley JC, van Berckel BN, Rozemuller A, Boellaard R, Huisman MC, Lammertsma AA, Vandertop WP, Molthoff CF. Increased cerebral (R)-[(11)C]PK11195 uptake and glutamate release in a rat model of traumatic brain injury: a longitudinal pilot study. Journal of Neuroinflammation. 8: 67. PMID 21672189 DOI: 10.1186/1742-2094-8-67  0.31
2011 van Velden FH, Cheebsumon P, Yaqub M, Smit EF, Hoekstra OS, Lammertsma AA, Boellaard R. Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. European Journal of Nuclear Medicine and Molecular Imaging. 38: 1636-47. PMID 21617975 DOI: 10.1007/S00259-011-1845-6  0.413
2011 Syvänen S, de Lange EC, Tagawa Y, Schenke M, Molthoff CF, Windhorst AD, Lammertsma AA, Voskuyl RA. Simultaneous in vivo measurements of receptor density and affinity using [11C]flumazenil and positron emission tomography: comparison of full saturation and steady state methods. Neuroimage. 57: 928-37. PMID 21609773 DOI: 10.1016/J.Neuroimage.2011.05.022  0.317
2011 Ten Cate TJ, Knaapen P, Lammertsma AA, De Cock CC, Van Hemel NM, Verzijlbergen JF. Effects of pacing rates on global and regional myocardial blood flow. Pacing and Clinical Electrophysiology : Pace. 34: 587-92. PMID 21609339 DOI: 10.1111/J.1540-8159.2010.03013.X  0.322
2011 Vermeltfoort IA, Raijmakers PG, Lubberink M, Germans T, van Rossum AC, Lammertsma AA, Knaapen P. Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 18: 650-6. PMID 21519976 DOI: 10.1007/S12350-011-9375-Y  0.426
2011 Harms HJ, de Haan S, Knaapen P, Allaart CP, Lammertsma AA, Lubberink M. Parametric images of myocardial viability using a single 15O-H2O PET/CT scan. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 745-9. PMID 21498530 DOI: 10.2967/Jnumed.110.085431  0.324
2011 Timmer SA, Knaapen P, Germans T, Dijkmans PA, Lubberink M, Ten Berg JM, Ten Cate FJ, Rüssel IK, Götte MJ, Lammertsma AA, van Rossum AC. Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology. 301: H129-37. PMID 21490327 DOI: 10.1152/Ajpheart.00077.2011  0.344
2011 Timmer SA, Germans T, Götte MJ, Rüssel IK, Lubberink M, Ten Berg JM, Ten Cate FJ, Lammertsma AA, Knaapen P, van Rossum AC. Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury. The American Journal of Cardiology. 107: 1522-8. PMID 21377644 DOI: 10.1016/J.Amjcard.2011.01.029  0.348
2011 Harms HJ, Knaapen P, de Haan S, Halbmeijer R, Lammertsma AA, Lubberink M. Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner. European Journal of Nuclear Medicine and Molecular Imaging. 38: 930-9. PMID 21271246 DOI: 10.1007/S00259-011-1730-3  0.367
2011 Cheebsumon P, Velasquez LM, Hoekstra CJ, Hayes W, Kloet RW, Hoetjes NJ, Smit EF, Hoekstra OS, Lammertsma AA, Boellaard R. Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis. European Journal of Nuclear Medicine and Molecular Imaging. 38: 832-42. PMID 21210109 DOI: 10.1007/S00259-010-1705-9  0.397
2011 Syvänen S, Luurtsema G, Molthoff CF, Windhorst AD, Huisman MC, Lammertsma AA, Voskuyl RA, de Lange EC. (R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus. Bmc Medical Imaging. 11: 1. PMID 21199574 DOI: 10.1186/1471-2342-11-1  0.332
2011 Lubberink M, Wong YY, Raijmakers PG, Schuit RC, Luurtsema G, Boellaard R, Knaapen P, Vonk-Noordegraaf A, Lammertsma AA. Myocardial oxygen extraction fraction measured using bolus inhalation of 15O-oxygen gas and dynamic PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 60-6. PMID 21149492 DOI: 10.2967/Jnumed.110.080408  0.313
2011 Timmer SA, Lubberink M, van Rossum AC, Lammertsma AA, Knaapen P. Reappraisal of a single-tissue compartment model for estimation of myocardial oxygen consumption by [11C]acetate PET: an alternative to conventional monoexponential curve fitting. Nuclear Medicine Communications. 32: 59-62. PMID 21048521 DOI: 10.1097/Mnm.0B013E32834113B0  0.401
2011 Bremmer JP, van Berckel BN, Persoon S, Kappelle LJ, Lammertsma AA, Kloet R, Luurtsema G, Rijbroek A, Klijn CJ, Boellaard R. Day-to-day test-retest variability of CBF, CMRO2, and OEF measurements using dynamic 15O PET studies. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 759-68. PMID 20700768 DOI: 10.1007/S11307-010-0382-1  0.367
2011 Harms HJ, Huisman MC, Knaapen P, Lammertsma AA, Lubberink M. Parametric imaging of myocardial blood flow and viability using [ 15O]H2O and PET/CT Imaging in Medicine. 3: 711-724. DOI: 10.2217/Iim.11.58  0.36
2011 Danad I, Raijmakers PG, Appelman YE, Harms HJ, Haan Sd, Oever MLPvd, Kuijk Cv, Allaart CP, Hoekstra OS, Lammertsma AA, Lubberink M, Rossum ACv, Knaapen P. Quantitative Relationship Between Coronary Calcium Score And Hyperaemic Myocardial Blood Flow As Assessed By Hybrid [15O]Pet/Ct Imaging In Patients Evaluated For Coronary Artery Disease Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)61877-9  0.376
2011 Danad I, Raijmakers PG, Appelman YE, Harms H, De Haan S, van den Oever ML, van Kuijk C, Allaart CP, Hoekstra OS, Lammertsma AA, Lubberink M, van Rossum AC, Knaapen P. DEFINING THE NORMAL LIMITS OF MYOCARDIAL BLOOD FLOW IN PATIENTS EVALUATED FOR CORONARY ARTERY DISEASE BY MEANS OF [15O] POSITRON EMISSION TOMOGRAPHY: IMPACT OF GENDER AND RISK PROFILE Journal of the American College of Cardiology. 57: E651. DOI: 10.1016/S0735-1097(11)60651-7  0.364
2011 Ossenkoppele R, Vrenken H, Tolboom N, Versteeg A, Schijndel Rv, Yaqub M, Boellaard R, Flier WVd, Barkhof F, Lammertsma A, Scheltens P, Berckel BNMv. Structural and molecular changes along the continuum of Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.184  0.401
2010 van der Veldt AA, Hendrikse NH, Harms HJ, Comans EF, Postmus PE, Smit EF, Lammertsma AA, Lubberink M. Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1684-90. PMID 20956480 DOI: 10.2967/Jnumed.110.079137  0.402
2010 Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, Pijnenburg YA, Lammertsma AA, Scheltens P, van Berckel BN. Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings. Alzheimer Disease and Associated Disorders. 24: 303-7. PMID 20683187 DOI: 10.1097/Wad.0B013E3181Cf35Ec  0.325
2010 Rijzewijk LJ, Jonker JT, van der Meer RW, Lubberink M, de Jong HW, Romijn JA, Bax JJ, de Roos A, Heine RJ, Twisk JW, Windhorst AD, Lammertsma AA, Smit JW, Diamant M, Lamb HJ. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. Journal of the American College of Cardiology. 56: 225-33. PMID 20620743 DOI: 10.1016/J.Jacc.2010.02.049  0.317
2010 van der Veldt AA, Hendrikse NH, Smit EF, Mooijer MP, Rijnders AY, Gerritsen WR, van der Hoeven JJ, Windhorst AD, Lammertsma AA, Lubberink M. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1950-8. PMID 20508935 DOI: 10.1007/S00259-010-1489-Y  0.359
2010 Hoetjes NJ, van Velden FH, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA, Boellaard R. Partial volume correction strategies for quantitative FDG PET in oncology. European Journal of Nuclear Medicine and Molecular Imaging. 37: 1679-87. PMID 20422184 DOI: 10.1007/S00259-010-1472-7  0.379
2010 Lubberink M, Harms HJ, Halbmeijer R, de Haan S, Knaapen P, Lammertsma AA. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 575-80. PMID 20237035 DOI: 10.2967/Jnumed.109.070748  0.403
2010 Knaapen P, de Haan S, Hoekstra OS, Halbmeijer R, Appelman YE, Groothuis JG, Comans EF, Meijerink MR, Lammertsma AA, Lubberink M, Götte MJ, van Rossum AC. Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation. 18: 90-8. PMID 20200615 DOI: 10.1007/Bf03091744  0.395
2010 Luurtsema G, Boellaard R, Greuter HN, Rijbroek A, Takkenkamp K, de Geest FG, Buijs FL, Harry Hendrikse N, Franssen EJ, van Lingen A, Lammertsma AA. Pharmaceutical preparation of oxygen-15 labelled molecular oxygen and carbon monoxide gasses in a hospital setting. Journal of Clinical Pharmacy and Therapeutics. 35: 63-9. PMID 20175813 DOI: 10.1111/J.1365-2710.2009.01032.X  0.307
2010 Timmer SA, Germans T, Götte MJ, Rüssel IK, Dijkmans PA, Lubberink M, ten Berg JM, ten Cate FJ, Lammertsma AA, Knaapen P, van Rossum AC. Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging. 37: 779-88. PMID 20069294 DOI: 10.1007/S00259-009-1350-3  0.34
2010 Timmer SA, Lubberink M, Germans T, Götte MJ, ten Berg JM, ten Cate FJ, van Rossum AC, Lammertsma AA, Knaapen P. Potential of [11C]acetate for measuring myocardial blood flow: Studies in normal subjects and patients with hypertrophic cardiomyopathy. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 17: 264-75. PMID 20039151 DOI: 10.1007/S12350-009-9181-Y  0.392
2010 Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, ... ... Lammertsma AA, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging. 37: 181-200. PMID 19915839 DOI: 10.1007/S00259-009-1297-4  0.392
2010 Klumpers UM, Veltman DJ, Drent ML, Boellaard R, Comans EF, Meynen G, Lammertsma AA, Hoogendijk WJ. Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging. 37: 565-74. PMID 19890631 DOI: 10.1007/S00259-009-1292-9  0.591
2010 Mourik JE, Lubberink M, van Velden FH, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. In vivo validation of reconstruction-based resolution recovery for human brain studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 381-9. PMID 19844240 DOI: 10.1038/Jcbfm.2009.225  0.319
2010 Bokkers RP, Bremmer JP, van Berckel BN, Lammertsma AA, Hendrikse J, Pluim JP, Kappelle LJ, Boellaard R, Klijn CJ. Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 222-9. PMID 19809464 DOI: 10.1038/Jcbfm.2009.204  0.397
2010 Yaqub M, Tolboom N, van Berckel BN, Scheltens P, Lammertsma AA, Boellaard R. Simplified parametric methods for [18F]FDDNP studies. Neuroimage. 49: 433-41. PMID 19643186 DOI: 10.1016/J.Neuroimage.2009.07.046  0.334
2010 van Assema DM, Lubberink M, Hoetjes NJ, Hendrikse HH, Schuit RC, Windhorst AD, der Flier WMv, Scheltens P, Lammertsma AA, van Berckel BN. Decreased P-glycoprotein function at the blood–brain barrier in patients with Alzheimer's disease as shown by (R)-[11C]verapamil and PET Neuroimage. 52: S53. DOI: 10.1016/J.Neuroimage.2010.04.234  0.359
2010 Molthoff CF, Folkersma H, Foster-Dingley JC, van Berckel BN, Rozemuller-Kwakkel AM, Boellaard R, Huisman M, Lammertsma AA, Vandertop WP. Combined microdialysis and longitudinal (R)-[11C]PK11195 PET study Neuroimage. 52: S35. DOI: 10.1016/J.Neuroimage.2010.04.217  0.365
2010 Verbeek J, Syvänen S, Luurtsema G, de Lange E, Eriksson J, Windhorst A, Lammertsma A. Initial PET studies in rats with novel radiotracer [11C]D617 and comparison with (R)-[11C]verapamil Neuroimage. 52: S26. DOI: 10.1016/J.Neuroimage.2010.04.210  0.342
2010 Klumpers UM, Boellaard R, Veltman DJ, Kloet RW, Hoogendijk WJ, Lammertsma AA. Parametric methods for quantification of [11C]Flumazenil studies Neuroimage. 52: S189. DOI: 10.1016/J.Neuroimage.2010.04.154  0.577
2010 Schuitemaker A, Kropholler MA, Boellaard R, van der Flier WM, Kloet RW, Knol DL, Windhorst AD, Jonker C, Lammertsma AA, Barkhof F, Scheltens P, van Berckel BN. Increased microglial activation in MCI and AD: An (R)-[11C]PK11195 PET study Neuroimage. 52: S146. DOI: 10.1016/J.Neuroimage.2010.04.120  0.35
2010 Ossenkoppele R, Tolboom N, Foster-Dingley J, Boellaard R, Yaqub M, Windhorst AD, Flier WMvd, Barkhof F, Lammertsma AA, Scheltens P, Berckel BNMv. First ever longitudinal [11C]PIB and [18F]FDDNP PET studies in patients with Alzheimer's disease or mild cognitive impairment and healthy controls Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.214  0.346
2009 Tolboom N, van der Flier WM, Yaqub M, Koene T, Boellaard R, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment. Neurology. 73: 2079-85. PMID 20018636 DOI: 10.1212/Wnl.0B013E3181C679Cc  0.32
2009 Nogová L, Boellaard R, Kobe C, Hoetjes N, Zander T, Gross SH, Dimitrijevic S, Pellas T, Eschner W, Schmidt K, Bangard C, Hayes W, Thomas RK, Dietlein M, Giaccone G, ... ... Lammertsma AA, et al. Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1815-9. PMID 19837761 DOI: 10.2967/Jnumed.109.065367  0.381
2009 Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA, Bax JJ, de Roos A, Twisk JW, Heine RJ, Lammertsma AA, Smit JW, Diamant M. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. Journal of the American College of Cardiology. 54: 1524-32. PMID 19815124 DOI: 10.1016/J.Jacc.2009.04.074  0.324
2009 Velasquez LM, Boellaard R, Kollia G, Hayes W, Hoekstra OS, Lammertsma AA, Galbraith SM. Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1646-54. PMID 19759105 DOI: 10.2967/Jnumed.109.063347  0.4
2009 Tolboom N, van der Flier WM, Yaqub M, Boellaard R, Verwey NA, Blankenstein MA, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1464-70. PMID 19690025 DOI: 10.2967/Jnumed.109.064360  0.36
2009 Luurtsema G, Schuit RC, Klok RP, Verbeek J, Leysen JE, Lammertsma AA, Windhorst AD. Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats. Nuclear Medicine and Biology. 36: 643-9. PMID 19647170 DOI: 10.1016/J.Nucmedbio.2009.03.004  0.343
2009 van den Brom CE, Huisman MC, Vlasblom R, Boontje NM, Duijst S, Lubberink M, Molthoff CF, Lammertsma AA, van der Velden J, Boer C, Ouwens DM, Diamant M. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography. Cardiovascular Diabetology. 8: 39. PMID 19624828 DOI: 10.1186/1475-2840-8-39  0.332
2009 Mourik JE, Lubberink M, van Velden FH, Lammertsma AA, Boellaard R. Off-line motion correction methods for multi-frame PET data. European Journal of Nuclear Medicine and Molecular Imaging. 36: 2002-13. PMID 19585116 DOI: 10.1007/S00259-009-1193-Y  0.302
2009 Tolboom N, Yaqub M, Boellaard R, Luurtsema G, Windhorst AD, Scheltens P, Lammertsma AA, van Berckel BN. Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 36: 1629-38. PMID 19384547 DOI: 10.1007/S00259-009-1129-6  0.341
2009 van Velden FH, Kloet RW, van Berckel BN, Buijs FL, Luurtsema G, Lammertsma AA, Boellaard R. HRRT versus HR+ human brain PET studies: an interscanner test-retest study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 693-702. PMID 19372482 DOI: 10.2967/Jnumed.108.058628  0.403
2009 Yaqub M, Boellaard R, van Berckel BN, Tolboom N, Luurtsema G, Dijkstra AA, Lubberink M, Windhorst AD, Scheltens P, Lammertsma AA. Evaluation of tracer kinetic models for analysis of [18F]FDDNP studies. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 322-33. PMID 19340487 DOI: 10.1007/S11307-009-0208-1  0.327
2009 Wolfensberger SP, van Berckel BN, Airaksinen AJ, Maruyama K, Lubberink M, Boellaard R, Carey WD, Reddingius W, Veltman DJ, Windhorst AD, Leysen JE, Lammertsma AA. First evaluation of [11C]R116301 as an in vivo tracer of NK1 receptors in man. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 241-5. PMID 19333655 DOI: 10.1007/S11307-009-0204-5  0.623
2009 Saridin CP, Raijmakers PG, Kloet RW, Tuinzing DB, Becking AG, Lammertsma AA. No signs of metabolic hyperactivity in patients with unilateral condylar hyperactivity: an in vivo positron emission tomography study. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 67: 576-81. PMID 19231783 DOI: 10.1016/J.Joms.2008.09.021  0.383
2009 de Jong HW, Rijzewijk LJ, Lubberink M, van der Meer RW, Lamb HJ, Smit JW, Diamant M, Lammertsma AA. Kinetic models for analysing myocardial [(11)C]palmitate data. European Journal of Nuclear Medicine and Molecular Imaging. 36: 966-78. PMID 19172268 DOI: 10.1007/S00259-008-1035-3  0.315
2009 Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 191-7. PMID 19164243 DOI: 10.2967/Jnumed.108.056499  0.371
2009 van Velden FH, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. Accuracy of 3-dimensional reconstruction algorithms for the high-resolution research tomograph. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 72-80. PMID 19091902 DOI: 10.2967/Jnumed.108.052985  0.31
2009 Kropholler MA, Boellaard R, Elzinga EH, van der Laken CJ, Maruyama K, Kloet RW, Voskuyl AE, Dijkmans BA, Lammertsma AA. Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis. European Journal of Nuclear Medicine and Molecular Imaging. 36: 624-31. PMID 19043704 DOI: 10.1007/S00259-008-0987-7  0.359
2009 Mourik JE, Lubberink M, Schuitemaker A, Tolboom N, van Berckel BN, Lammertsma AA, Boellaard R. Image-derived input functions for PET brain studies. European Journal of Nuclear Medicine and Molecular Imaging. 36: 463-71. PMID 19030855 DOI: 10.1007/S00259-008-0986-8  0.347
2009 de Langen AJ, Klabbers B, Lubberink M, Boellaard R, Spreeuwenberg MD, Slotman BJ, de Bree R, Smit EF, Hoekstra OS, Lammertsma AA. Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 36: 389-95. PMID 18931838 DOI: 10.1007/S00259-008-0960-5  0.364
2009 Liefaard LC, Ploeger BA, Molthoff CF, de Jong HW, Dijkstra J, van der Weerd L, Lammertsma AA, Danhof M, Voskuyl RA. Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography. Epilepsia. 50: 88-98. PMID 18727682 DOI: 10.1111/J.1528-1167.2008.01763.X  0.33
2009 Rijbroek A, Boellaard R, Vriens EM, Lammertsma AA, Rauwerda JA. Comparison of transcranial Doppler ultrasonography and positron emission tomography using a three-dimensional template of the middle cerebral artery. Neurological Research. 31: 52-9. PMID 18662500 DOI: 10.1179/174313208X325191  0.391
2009 Rijbroek A, Boellaard R, Vermeulen EG, Lammertsma AA, Rauwerda JA. Hemodynamic changes in ipsi- and contralateral cerebral arterial territories after carotid endarterectomy using positron emission tomography. Surgical Neurology. 71: 668-76, discussion 6. PMID 18614216 DOI: 10.1016/J.Surneu.2008.04.027  0.355
2009 Berckel Bv, Tolboom N, Yaqub M, Koene T, Boellaard R, Scheltens P, Lammertsma AA, Flier WMvd. Increased [11C]PET And [18F]FDDNP Binding Are Selectively Associated With Memory Impairment Alzheimers & Dementia. 5. DOI: 10.1016/J.Jalz.2009.07.143  0.333
2008 Lammertsma AA, Boellaard R, Hoekstra OS. Quantitative Issues in Response Measurement by PET. Pet Clinics. 3: 5-11. PMID 27158144 DOI: 10.1016/J.Cpet.2008.08.003  0.369
2008 Luurtsema G, Schuit RC, Takkenkamp K, Lubberink M, Hendrikse NH, Windhorst AD, Molthoff CF, Tolboom N, van Berckel BN, Lammertsma AA. Peripheral metabolism of [(18)F]FDDNP and cerebral uptake of its labelled metabolites. Nuclear Medicine and Biology. 35: 869-74. PMID 19026948 DOI: 10.1016/J.Nucmedbio.2008.09.002  0.371
2008 van der Laken CJ, Elzinga EH, Kropholler MA, Molthoff CF, van der Heijden JW, Maruyama K, Boellaard R, Dijkmans BA, Lammertsma AA, Voskuyl AE. Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography. Arthritis and Rheumatism. 58: 3350-5. PMID 18975347 DOI: 10.1002/Art.23955  0.373
2008 de Langen AJ, Lubberink M, Boellaard R, Spreeuwenberg MD, Smit EF, Hoekstra OS, Lammertsma AA. Reproducibility of tumor perfusion measurements using 15O-labeled water and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1763-8. PMID 18927324 DOI: 10.2967/Jnumed.108.053454  0.358
2008 Mourik JE, van Velden FH, Lubberink M, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. Image derived input functions for dynamic High Resolution Research Tomograph PET brain studies. Neuroimage. 43: 676-86. PMID 18707007 DOI: 10.1016/J.Neuroimage.2008.07.035  0.389
2008 Direcks WG, Berndsen SC, Proost N, Peters GJ, Balzarini J, Spreeuwenberg MD, Lammertsma AA, Molthoff CF. [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study. British Journal of Cancer. 99: 481-7. PMID 18665170 DOI: 10.1038/Sj.Bjc.6604523  0.355
2008 Yaqub M, Tolboom N, Boellaard R, van Berckel BN, van Tilburg EW, Luurtsema G, Scheltens P, Lammertsma AA. Simplified parametric methods for [11C]PIB studies. Neuroimage. 42: 76-86. PMID 18541442 DOI: 10.1016/J.Neuroimage.2008.04.251  0.33
2008 van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biological Psychiatry. 64: 820-2. PMID 18534557 DOI: 10.1016/J.Biopsych.2008.04.025  0.335
2008 Knaapen P, Lubberink M, Rijzewijk LJ, van der Meer RW, Unger M, Germans T, Bax JJ, Smit JW, Lamb HJ, van Rossum AC, Diamant M, Visser FC, Lammertsma AA. Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 15: 218-24. PMID 18371593 DOI: 10.1016/J.Nuclcard.2007.11.016  0.343
2008 Direcks WG, van Gelder M, Lammertsma AA, Molthoff CF. A new rat model of human breast cancer for evaluating efficacy of new anti-cancer agents in vivo. Cancer Biology & Therapy. 7: 532-7. PMID 18296913 DOI: 10.4161/Cbt.7.4.5481  0.342
2008 Rijbroek A, Boellaard R, Vriens EM, Lammertsma AA, Rauwerda JA. Peroperative neuromonitoring during carotid endarterectomy in relation to preoperative positron emission tomography findings. European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 35: 652-60. PMID 18295516 DOI: 10.1016/J.Ejvs.2008.01.010  0.407
2008 van Velden FH, Kloet RW, van Berckel BN, Molthoff CF, de Jong HW, Lammertsma AA, Boellaard R. Impact of attenuation correction strategies on the quantification of High Resolution Research Tomograph PET studies. Physics in Medicine and Biology. 53: 99-118. PMID 18182690 DOI: 10.1088/0031-9155/53/1/007  0.338
2008 Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM, Dijkmans PA, Boellaard R, van Dockum WG, Götte MJ, Twisk JW, van Rossum AC, Lammertsma AA, Visser FC. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. American Journal of Physiology. Heart and Circulatory Physiology. 294: H986-93. PMID 18156203 DOI: 10.1152/Ajpheart.00233.2007  0.335
2008 Mourik JE, Lubberink M, Klumpers UM, Comans EF, Lammertsma AA, Boellaard R. Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C]flumazenil. Neuroimage. 39: 1041-50. PMID 18042494 DOI: 10.1016/J.Neuroimage.2007.10.022  0.363
2008 Klumpers UM, Veltman DJ, Boellaard R, Comans EF, Zuketto C, Yaqub M, Mourik JE, Lubberink M, Hoogendijk WJ, Lammertsma AA. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 579-87. PMID 17928801 DOI: 10.1038/Sj.Jcbfm.9600554  0.602
2008 Abrahim A, Luurtsema G, Bauer M, Karch R, Lubberink M, Pataraia E, Joukhadar C, Kletter K, Lammertsma AA, Baumgartner C, Müller M, Langer O. Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients. European Journal of Nuclear Medicine and Molecular Imaging. 35: 116-23. PMID 17846766 DOI: 10.1007/S00259-007-0556-5  0.355
2008 Geuze E, van Berckel BN, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E, Westenberg HG. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Molecular Psychiatry. 13: 74-83, 3. PMID 17667960 DOI: 10.1038/Sj.Mp.4002054  0.341
2008 Lubberink M, Luurtsema G, Yaqub M, Tolboom N, van Berckel B, Lammertsma A. Parametric binding potential images of [11C]PIB and [18F]FDDNP and their radioactive metabolites using spectral analysis Neuroimage. 41: T29. DOI: 10.1016/J.Neuroimage.2008.04.203  0.325
2008 Klumpers UM, Mutluer K, Veltman D, vanBerckel B, Boellaard R, Windhorst B, Hoogendijk W, Lammertsma A. D2 receptor reactivity after total sleep deprivation: Preliminary results in healthy subjects Neuroimage. 41: T128. DOI: 10.1016/J.Neuroimage.2008.04.096  0.541
2008 Tolboom NS, Flier WMvd, Yaqub M, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, Berckel BNMv. Detecting Alzheimer pathology in vivo: Comparing regional binding of [11C]PIB and [18F]FDDNP Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.086  0.324
2008 Mourik JEM, Lubberink M, Schuitemaker A, Tolboom N, Berckel BNMv, Lammertsma AA, Boellaard R. Use of image derived input functions for [11C]PIB, (R)-[11C]verapamil and (R)-[11C]PK11195 brain studies: Assessment of accuracy and test–retest variability Neuroimage. 41. DOI: 10.1016/J.Neuroimage.2008.04.044  0.307
2008 van Berckel BN, Lubberink M, Luurtsema G, Boellaard R, Lammertsma A. P4-292: Regional variations in age dependence of P-gp-mediated transport across the blood-brain barrier measured using (R )-[11 C]verapamil and PET Alzheimer's & Dementia. 4: T757-T757. DOI: 10.1016/J.Jalz.2008.05.2361  0.339
2008 van Berckel B, Lubberink M, Luurtsema G, Boellaard R, Lammertsma A. IC-P3-224: Regional variations in age dependence of P-gp mediated transport across the blood-brain barrier measured using (R )-[11 C]verapamil and positron emission tomography Alzheimer's & Dementia. 4: T95-T95. DOI: 10.1016/J.Jalz.2008.05.169  0.338
2008 Tolboom N, Yaqub M, Flier WMVd, Boellaard R, Luurtsema G, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, Berckel BNMV. IC-03-01: Imaging Alzheimer pathology in vivo: Quantitative comparison of [11C]PIB and [18F]FDDNP Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.006  0.306
2007 van der Veldt AA, Lammertsma AA, Hendrikse NH. [11C]docetaxel and positron emission tomography for noninvasive measurements of docetaxel kinetics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7522; author reply 7. PMID 18094438 DOI: 10.1158/1078-0432.Ccr-07-1626  0.344
2007 Marques KM, Knaapen P, Boellaard R, Lammertsma AA, Westerhof N, Visser FC. Microvascular function in viable myocardium after chronic infarction does not influence fractional flow reserve measurements. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1987-92. PMID 18006610 DOI: 10.2967/Jnumed.107.044370  0.354
2007 Elzinga EH, van der Laken CJ, Comans EF, Lammertsma AA, Dijkmans BA, Voskuyl AE. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 9: 357-60. PMID 17902022 DOI: 10.1007/S11307-007-0113-4  0.34
2007 Marques KM, Knaapen P, Boellaard R, Westerhof N, Lammertsma AA, Visser CA, Visser FC. Hyperaemic microvascular resistance is not increased in viable myocardium after chronic myocardial infarction. European Heart Journal. 28: 2320-5. PMID 17656351 DOI: 10.1093/Eurheartj/Ehm309  0.361
2007 Molthoff CF, Klabbers BM, Berkhof J, Felten JT, van Gelder M, Windhorst AD, Slotman BJ, Lammertsma AA. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT). Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 9: 340-7. PMID 17643202 DOI: 10.1007/S11307-007-0104-5  0.367
2007 Soliman OI, Knaapen P, Geleijnse ML, Dijkmans PA, Anwar AM, Nemes A, Michels M, Vletter WB, Lammertsma AA, ten Cate FJ. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography. Heart (British Cardiac Society). 93: 1204-12. PMID 17488767 DOI: 10.1136/Hrt.2006.110460  0.367
2007 Kropholler MA, Boellaard R, van Berckel BN, Schuitemaker A, Kloet RW, Lubberink MJ, Jonker C, Scheltens P, Lammertsma AA. Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1965-74. PMID 17406654 DOI: 10.1038/Sj.Jcbfm.9600488  0.33
2007 Schuitemaker A, van Berckel BN, Kropholler MA, Veltman DJ, Scheltens P, Jonker C, Lammertsma AA, Boellaard R. SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods. Neuroimage. 35: 1473-9. PMID 17363280 DOI: 10.1016/J.Neuroimage.2007.02.013  0.625
2007 van der Weerdt AP, Boellaard R, Visser FC, Lammertsma AA. Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner. European Journal of Nuclear Medicine and Molecular Imaging. 34: 1439-46. PMID 17333179 DOI: 10.1007/S00259-007-0367-8  0.324
2007 Schuitemaker A, van Berckel BN, Kropholler MA, Kloet RW, Jonker C, Scheltens P, Lammertsma AA, Boellaard R. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1603-15. PMID 17311080 DOI: 10.1038/Sj.Jcbfm.9600459  0.386
2007 Yaqub M, Boellaard R, van Berckel BN, Ponsen MM, Lubberink M, Windhorst AD, Berendse HW, Lammertsma AA. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1397-406. PMID 17191076 DOI: 10.1038/Sj.Jcbfm.9600439  0.346
2007 van Campen CM, Visser FC, van der Weerdt AP, Knaapen P, Comans EF, Lammertsma AA, de Cock CC, Visser CA. FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging. 34: 309-15. PMID 17021810 DOI: 10.1007/S00259-006-0235-Y  0.377
2007 Lubberink M, Luurtsema G, van Berckel BN, Boellaard R, Toornvliet R, Windhorst AD, Franssen EJ, Lammertsma AA. Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 424-33. PMID 16757979 DOI: 10.1038/Sj.Jcbfm.9600349  0.363
2007 Bax JJ, Beanlands RS, Klocke FJ, Knuuti J, Lammertsma AA, Schaefers MA, Schelbert HR, Von Schulthess GK, Shaw LJ, Yang GZ, Camici PG. Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? Heart (British Cardiac Society). 93: 16-22. PMID 16387827 DOI: 10.1136/Hrt.2005.075283  0.32
2006 Blok BF, Groen J, Bosch JL, Veltman DJ, Lammertsma AA. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. Bju International. 98: 1238-43. PMID 17034500 DOI: 10.1111/J.1464-410X.2006.06521.X  0.589
2006 Knaapen P, van Dockum WG, Götte MJ, Broeze KA, Kuijer JP, Zwanenburg JJ, Marcus JT, Kok WE, van Rossum AC, Lammertsma AA, Visser FC. Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 13: 660-7. PMID 16945746 DOI: 10.1016/J.Nuclcard.2006.05.018  0.36
2006 Airaksinen AJ, Jablonowski JA, van der Mey M, Barbier AJ, Klok RP, Verbeek J, Schuit R, Herscheid JD, Leysen JE, Carruthers NI, Lammertsma AA, Windhorst AD. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand. Nuclear Medicine and Biology. 33: 801-10. PMID 16934699 DOI: 10.1016/J.Nucmedbio.2006.05.008  0.313
2006 Yaqub M, Boellaard R, Kropholler MA, Lammertsma AA. Optimization algorithms and weighting factors for analysis of dynamic PET studies. Physics in Medicine and Biology. 51: 4217-32. PMID 16912378 DOI: 10.1088/0031-9155/51/17/007  0.33
2006 Knaapen P, Götte MJ, Paulus WJ, Zwanenburg JJ, Dijkmans PA, Boellaard R, Marcus JT, Twisk JW, Visser CA, van Rossum AC, Lammertsma AA, Visser FC. Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study. Radiology. 240: 380-8. PMID 16864667 DOI: 10.1148/Radiol.2402051038  0.397
2006 Knaapen P, Bondarenko O, Beek AM, Götte MJ, Boellaard R, van der Weerdt AP, Visser CA, van Rossum AC, Lammertsma AA, Visser FC. Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: Evaluation with PET and contrast-enhanced MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 8: 245-51. PMID 16791751 DOI: 10.1007/S11307-006-0044-5  0.353
2006 Toornvliet R, van Berckel BN, Luurtsema G, Lubberink M, Geldof AA, Bosch TM, Oerlemans R, Lammertsma AA, Franssen EJ. Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography. Clinical Pharmacology and Therapeutics. 79: 540-8. PMID 16765142 DOI: 10.1016/J.Clpt.2006.02.004  0.302
2006 Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. How should we analyse FDG PET studies for monitoring tumour response? European Journal of Nuclear Medicine and Molecular Imaging. 33: 16-21. PMID 16763817 DOI: 10.1007/S00259-006-0131-5  0.327
2006 Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2133-40. PMID 16609026 DOI: 10.1158/1078-0432.Ccr-05-2137  0.384
2006 Kropholler MA, Boellaard R, Schuitemaker A, Folkersma H, van Berckel BN, Lammertsma AA. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1431-41. PMID 16511500 DOI: 10.1038/Sj.Jcbfm.9600289  0.327
2006 Dijkmans PA, Knaapen P, Sieswerda GT, Aiazian E, Visser CA, Lammertsma AA, Visser FC, Kamp O. Quantification of myocardial perfusion using intravenous myocardial contrast echocardiography in healthy volunteers: comparison with positron emission tomography. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 19: 285-93. PMID 16500491 DOI: 10.1016/J.Echo.2005.10.009  0.432
2006 Schuitemaker A, van Berckel B, Boellaard R, Kropholler M, Jonker C, Lubberink M, Scheltens P, Lammertsma A. Assessment of microglial activation in mild cognitive impairment using [11C](R)-PK11195 and PET Neuroimage. 31: T159. DOI: 10.1016/J.Neuroimage.2006.04.142  0.329
2006 Liefaard LC, Ploeger BA, Molthoff CFM, Boellaard R, Jong HWAMd, Lammertsma AA, Danhof M, Voskuyl RA. Alterations in GABAA receptor kinetics in epileptic rats studied in vivo using positron emission tomography Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.128  0.332
2006 Lubberink M, van Berckel B, Luurtsema G, Boellaard R, Toornvliet R, Franssen E, Windhorst A, Lammertsma A. Regional variations in age dependence of P-gp-mediated transport across the blood–brain barrier measured using (R)-[11C]verapamil and PET Neuroimage. 31: T110. DOI: 10.1016/J.Neuroimage.2006.04.096  0.33
2006 Klumpers U, Boellaard R, Veltman D, Kloet R, Comans E, Hoogendijk W, Lammertsma A. Parametric images of [11C]Flumazenil binding: Comparison of methods Neuroimage. 31: T76. DOI: 10.1016/J.Neuroimage.2006.04.066  0.586
2006 Lubberink M, Mourik J, Boellaard R, Lammertsma A. Automatic definition of image-derived input functions in brain PET images using clustering based on population arterial blood curves Neuroimage. 31: T69. DOI: 10.1016/J.Neuroimage.2006.04.059  0.336
2006 Yaqub M, Boellaard R, Berckel BNMV, Ponsen MM, Lubberink M, Windhorst AD, Berendse HW, Lammertsma AA. Quantification of dopamine transporter binding using [18F]FP-β-CIT and positron emission tomography Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.057  0.326
2006 Yaqub M, Boellaard R, Lammertsma A. Lifting wavelet transform for denoising PET time–activity curves: Effect on kinetic analyses Neuroimage. 31: T65. DOI: 10.1016/J.Neuroimage.2006.04.056  0.307
2006 Boellaard R, Yaqub M, Lubberink M, Lammertsma A. PPET: A software tool for kinetic and parametric analyses of dynamic PET studies Neuroimage. 31: T62. DOI: 10.1016/J.Neuroimage.2006.04.053  0.313
2005 Hofman HA, Knaapen P, Boellaard R, Bondarenko O, Götte MJ, van Dockum WG, Visser CA, van Rossum AC, Lammertsma AA, Visser FC. Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 12: 639-44. PMID 16344225 DOI: 10.1016/J.Nuclcard.2005.04.016  0.401
2005 Liefaard LC, Ploeger BA, Molthoff CF, Boellaard R, Lammertsma AA, Danhof M, Voskuyl RA. Population pharmacokinetic analysis for simultaneous determination of B (max) and K (D) in vivo by positron emission tomography. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 7: 411-21. PMID 16328648 DOI: 10.1007/S11307-005-0022-3  0.357
2005 Hoekstra CJ, Stroobants SG, Smit EF, Vansteenkiste J, van Tinteren H, Postmus PE, Golding RP, Biesma B, Schramel FJ, van Zandwijk N, Lammertsma AA, Hoekstra OS. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8362-70. PMID 16293866 DOI: 10.1200/Jco.2005.01.1189  0.389
2005 Boellaard R, Knaapen P, Rijbroek A, Luurtsema GJ, Lammertsma AA. Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and Positron Emission Tomography. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 7: 273-85. PMID 16080023 DOI: 10.1007/S11307-005-0007-2  0.388
2005 Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV. Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer. European Journal of Cancer (Oxford, England : 1990). 41: 1533-41. PMID 15953716 DOI: 10.1016/J.Ejca.2005.03.026  0.331
2005 Greuter HN, van Ophemert PL, Luurtsema G, van Berckel BN, Franssen EJ, Windhorst BD, Lammertsma AA. Optimizing an online SPE-HPLC method for analysis of (R)-[11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [(R)-[11C]PK11195] and its metabolites in humans. Nuclear Medicine and Biology. 32: 307-12. PMID 15820767 DOI: 10.1016/J.Nucmedbio.2004.12.005  0.316
2005 Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jonker C, Drent ML. Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology. 81: 31-40. PMID 15809510 DOI: 10.1159/000084872  0.582
2005 Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. European Journal of Nuclear Medicine and Molecular Imaging. 32: 294-301. PMID 15791438 DOI: 10.1007/S00259-004-1566-1  0.349
2005 Kropholler MA, Boellaard R, Schuitemaker A, van Berckel BN, Luurtsema G, Windhorst AD, Lammertsma AA. Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 842-51. PMID 15744248 DOI: 10.1038/Sj.Jcbfm.9600092  0.371
2005 Luurtsema G, Molthoff CF, Schuit RC, Windhorst AD, Lammertsma AA, Franssen EJ. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat. Nuclear Medicine and Biology. 32: 87-93. PMID 15691665 DOI: 10.1016/J.Nucmedbio.2004.06.007  0.36
2005 Boellaard R, Rijbroek A, Luurtsema G, Greuter HNJM, Lammertsma AA. Feasibility of deriving CBF, OEF and CMRO2 from a single dynamic PET scan using a short inhalation of oxygen-15 labelled molecular oxygen Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0671  0.312
2005 Klumpers UMH, Veltman DJ, Comans EFI, Kropholler MA, Boellaard R, Hoogendijk WJG, Lammertsma AA. Comparison of various models for analysing [11C]flumazenil studies Journal of Cerebral Blood Flow & Metabolism. 25: S660-S660. DOI: 10.1038/Sj.Jcbfm.9591524.0660  0.572
2005 Schuitemaker A, van Berckel BNM, Kropholler MA, Scheltens P, Jonker C, Veltman DJ, Lammertsma AA, Boellaard R. Effects of reference tissue versus plasma input parametric kinetic modelling on statistical parametric analysis of [11C](R)-PK11195 binding in Alzheimer's disease (AD) and young and old subjects Journal of Cerebral Blood Flow & Metabolism. 25: S643-S643. DOI: 10.1038/Sj.Jcbfm.9591524.0643  0.59
2005 Kropholler MA, van Berckel BNM, Schuitemaker A, Folkersma H, Luurtsema G, Windhorst AD, Boellaard R, Lammertsma AA. Evaluation of reference tissue models for analysing [11C](R)-PK11195 studies Journal of Cerebral Blood Flow & Metabolism. 25: S642-S642. DOI: 10.1038/Sj.Jcbfm.9591524.0642  0.326
2005 Yaqub M, Boellaard R, Kropholler M, Lubberink M, Lammertsma A. Improving accuracy and precision of PET pharmacokinetic analysis using wavelet based denoising of time activity curves Journal of Cerebral Blood Flow & Metabolism. 25: S640-S640. DOI: 10.1038/Sj.Jcbfm.9591524.0640  0.349
2005 Lubberink M, Luurtsema G, Boellaard R, Lammertsma AA. Multi-input spectral analysis for evaluation of the contribution of radioactive metabolites in (R)-[11C]verapamil PET data Journal of Cerebral Blood Flow & Metabolism. 25: S629-S629. DOI: 10.1038/Sj.Jcbfm.9591524.0629  0.359
2005 Liefaard LC, Ploeger BA, Molthoff CFM, Boellaard R, de Jong HWAM, Lammertsma AA, Danhof M, Voskuyl RA. Development of longitudinal PET studies for experimental animal models Journal of Cerebral Blood Flow & Metabolism. 25: S602-S602. DOI: 10.1038/Sj.Jcbfm.9591524.0602  0.342
2005 Wolfensberger SPA, Araiksinen AJ, Berckel BNMv, Boellaard R, Carey WDH, Reddingius W, Veltman DJ, Windhorst BD, Leysen JE, Lammertsma AA. Evaluation of |[lsqb]|C-11|[rsqb]|R116301 as a tracer for the in vivo measurement of NK1 receptors in human subjects Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0596  0.584
2005 Berckel BNMv, Boellaard R, Kropholler MA, Caspers E, Cahn W, Lammertsma AA, Kahn RS. Assessment of microglia activation in schizophrenia using |[lsqb]|11C|[rsqb]|(R)-PK11195 and PET Journal of Cerebral Blood Flow and Metabolism. 25. DOI: 10.1038/Sj.Jcbfm.9591524.0391  0.323
2005 Geuze E, van Berckel BNM, Boellaard R, Windhorst BD, Luurtsema G, Westenberg HGM, Lammertsma AA, Vermetten E. Changes in benzodiazepine receptor binding in Dutch veterans with posttraumatic stress disorder assessed with [C-11]-flumazenil and PET Journal of Cerebral Blood Flow & Metabolism. 25: S346-S346. DOI: 10.1038/Sj.Jcbfm.9591524.0346  0.318
2005 Schuitemaker A, van Berckel BNM, Boellaard R, Kropholler MA, Jonker C, Veltman DJ, Scheltens P, Lammertsma AA. Assessment of microglial activation in patients with Alzheimer's disease using [C-11]-(R)-PK11195 and PET Journal of Cerebral Blood Flow & Metabolism. 25: S318-S318. DOI: 10.1038/Sj.Jcbfm.9591524.0318  0.628
2005 Toornvliet JR, van Berckel BNM, Luurtsema G, Lubberink M, Geldof AA, Bosch TM, Lammertsma AA, Franssen EJF. Effect of age on blood brain barrier transport function studied with [11C](R)-verapamil and PET Journal of Cerebral Blood Flow & Metabolism. 25: S273-S273. DOI: 10.1038/Sj.Jcbfm.9591524.0273  0.349
2005 Dijkmans PA, Knaapen P, Sieswerda GT, Aiazian E, Visser CA, Lammertsma AA, Visser FC, Kamp O. 1078 Myocardial perfusion as determined with real-time myocardial contrast echocardiography correlates with positron emission tomography in healthy volunteers European Journal of Echocardiography. 6. DOI: 10.1016/S1525-2167(05)80631-6  0.366
2005 Borst G, Belderbos J, Boellaard R, Comans E, de Jaeger K, Lammertsma A, Lebesque J. O-145 Prognostic significance of the 18FDG-PET standardized uptake value for inoperable non-small cell lung cancer patients after high-dose radiotherapy Lung Cancer. 49: S50. DOI: 10.1016/S0169-5002(05)80279-X  0.347
2004 van den Heuvel OA, Veltman DJ, Groenewegen HJ, Dolan RJ, Cath DC, Boellaard R, Mesina CT, van Balkom AJ, van Oppen P, Witter MP, Lammertsma AA, van Dyck R. Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Research. 132: 225-37. PMID 15664794 DOI: 10.1016/J.Pscychresns.2004.06.007  0.702
2004 Veltman DJ, Tuinebreijer WE, Winkelman D, Lammertsma AA, Witter MP, Dolan RJ, Emmelkamp PM. Neurophysiological correlates of habituation during exposure in spider phobia. Psychiatry Research. 132: 149-58. PMID 15598549 DOI: 10.1016/J.Pscychresns.2004.09.001  0.587
2004 Luurtsema G, de Lange EC, Lammertsma AA, Franssen EJ. Transport across the blood-brain barrier: stereoselectivity and PET-tracers. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 306-18. PMID 15380740 DOI: 10.1016/J.Mibio.2004.06.008  0.33
2004 Knaapen P, van Campen LM, de Cock CC, Götte MJ, Visser CA, Lammertsma AA, Visser FC. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation. 110: 646-51. PMID 15302806 DOI: 10.1161/01.Cir.0000138108.68719.C1  0.312
2004 Krak NC, Hoekstra OS, Lammertsma AA. Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations. European Journal of Nuclear Medicine and Molecular Imaging. 31: S103-11. PMID 15103507 DOI: 10.1007/S00259-004-1532-Y  0.371
2004 van der Hoeven JJ, Krak NC, Hoekstra OS, Comans EF, Boom RP, van Geldere D, Meijer S, van der Wall E, Buter J, Pinedo HM, Teule GJ, Lammertsma AA. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1253-9. PMID 15051773 DOI: 10.1200/Jco.2004.07.058  0.383
2004 van Tilburg EW, Franssen EJF, van der Hoeven JJM, van der Meij M, Elshove D, Lammertsma AA, Windhorst AD. Radiosynthesis of[11C]docetaxel Journal of Labelled Compounds and Radiopharmaceuticals. 47: 763-777. DOI: 10.1002/Jlcr.861  0.303
2003 Boellaard R, de Jong HW, Molthoff CF, Buijs F, Lenox M, Nutt R, Lammertsma AA. Use of an in-field-of-view shield to improve count rate performance of the single crystal layer high-resolution research tomograph PET scanner for small animal brain scans. Physics in Medicine and Biology. 48: N335-42. PMID 14703172 DOI: 10.1088/0031-9155/48/23/N02  0.328
2003 Knaapen P, Boellaard R, Götte MJ, van der Weerdt AP, Visser CA, Lammertsma AA, Visser FC. The perfusable tissue index: a marker of myocardial viability. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 10: 684-91. PMID 14668782 DOI: 10.1016/S1071-3581(03)00656-1  0.379
2003 Kroep JR, Van Groeningen CJ, Cuesta MA, Craanen ME, Hoekstra OS, Comans EF, Bloemena E, Hoekstra CJ, Golding RP, Twisk JW, Peters GJ, Pinedo HM, Lammertsma AA. Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 337-46. PMID 14630513 DOI: 10.1016/J.Mibio.2003.09.007  0.411
2003 Zijlstra JM, Hoekstra OS, Raijmakers PG, Comans EF, van der Hoeven JJ, Teule GJ, Jonkhoff AR, v Tinteren H, Lammertsma AA, Huijgens PC. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. British Journal of Haematology. 123: 454-62. PMID 14617005 DOI: 10.1046/J.1365-2141.2003.04617.X  0.367
2003 Mesina CT, Boellaard R, van den Heuvel OA, Veltman DJ, Jongbloed G, van der Vaart AW, Lammertsma AA. Effects of attenuation correction and reconstruction method on PET activation studies. Neuroimage. 20: 898-908. PMID 14568460 DOI: 10.1016/S1053-8119(03)00379-3  0.587
2003 Luurtsema G, Molthoff CF, Windhorst AD, Smit JW, Keizer H, Boellaard R, Lammertsma AA, Franssen EJ. (R)- and (S)-[11C]verapamil as PET-tracers for measuring P-glycoprotein function: in vitro and in vivo evaluation. Nuclear Medicine and Biology. 30: 747-51. PMID 14499333 DOI: 10.1016/S0969-8051(03)00078-7  0.316
2003 Klabbers BM, Lammertsma AA, Slotman BJ. The value of positron emission tomography for monitoring response to radiotherapy in head and neck cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 257-70. PMID 14499141 DOI: 10.1016/S1536-1632(03)00102-1  0.396
2003 van den Heuvel OA, Boellaard R, Veltman DJ, Mesina C, Lammertsma AA. Attenuation correction of PET activation studies in the presence of task-related motion. Neuroimage. 19: 1501-9. PMID 12948706 DOI: 10.1016/S1053-8119(03)00216-7  0.606
2003 Mesina CT, Boellaard R, Jongbloed G, van der Vaart AW, Lammertsma AA. Experimental evaluation of iterative reconstruction versus filtered back projection for 3D [15O]water PET activation studies using statistical parametric mapping analysis. Neuroimage. 19: 1170-9. PMID 12880842 DOI: 10.1016/S1053-8119(03)00075-2  0.331
2003 Kühl HP, Beek AM, van der Weerdt AP, Hofman MB, Visser CA, Lammertsma AA, Heussen N, Visser FC, van Rossum AC. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. Journal of the American College of Cardiology. 41: 1341-8. PMID 12706930 DOI: 10.1016/S0735-1097(03)00158-X  0.333
2003 Mijnhout GS, Hoekstra OS, van Lingen A, van Diest PJ, Adèr HJ, Lammertsma AA, Pijpers R, Meijer S, Teule GJ. How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma. Journal of Clinical Pathology. 56: 283-6. PMID 12663640 DOI: 10.1136/Jcp.56.4.283  0.34
2003 Blokhuis TJ, Patka P, Bakker FC, Haarman HJ, van Lingen A, Roos JC, Lammertsma AA. Quantitative assessment of fracture healing using positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 30: 329-30. PMID 12645528 DOI: 10.1007/S00259-002-0986-Z  0.302
2003 Krak NC, van der Hoeven JJ, Hoekstra OS, Twisk JW, van der Wall E, Lammertsma AA. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods. European Journal of Nuclear Medicine and Molecular Imaging. 30: 674-81. PMID 12640556 DOI: 10.1007/S00259-003-1127-Z  0.375
2003 Boellaard R, Buijs F, de Jong HW, Lenox M, Gremillion T, Lammertsma AA. Characterization of a single LSO crystal layer high resolution research tomograph. Physics in Medicine and Biology. 48: 429-48. PMID 12630740 DOI: 10.1088/0031-9155/48/4/302  0.316
2002 Lammertsma AA. Radioligand studies: imaging and quantitative analysis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 513-6. PMID 12468014 DOI: 10.1016/S0924-977X(02)00100-1  0.361
2002 van der Hoeven JJ, Hoekstra OS, Comans EF, Pijpers R, Boom RP, van Geldere D, Meijer S, Lammertsma AA, Teule GJ. Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer. Annals of Surgery. 236: 619-24. PMID 12409668 DOI: 10.1097/00000658-200211000-00012  0.353
2002 Klabbers BM, de Munck JC, Slotman BJ, Langendijk HA, de Bree R, Hoekstra OS, Boellaard R, Lammertsma AA. Matching PET and CT scans of the head and neck area: development of method and validation. Medical Physics. 29: 2230-8. PMID 12408296 DOI: 10.1118/1.1508111  0.387
2002 van der Weerdt AP, Klein LJ, Visser CA, Visser FC, Lammertsma AA. Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping. European Journal of Nuclear Medicine and Molecular Imaging. 29: 663-9. PMID 11976805 DOI: 10.1007/S00259-002-0772-Y  0.344
2002 Franssen EJF, Greuter HNJM, Touw DJ, Luurtsema G, Windhorst AD, Lammertsma AA. Plasma pharmacokinetics of [11C]-flumazenil and its major metabolite [11C]-flumazenil ‘acid’ British Journal of Clinical Pharmacology. 53: 554P-555P. DOI: 10.1046/J.1365-2125.2002.161319.X  0.368
2001 Lammertsma AA. Measurement of tumor response using [18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography. Journal of Clinical Pharmacology. 104S-106S. PMID 11452713 DOI: 10.1177/0091270001417015  0.343
2001 Araujo LI, McFalls EO, Lammertsma AA, Jones T, Maseri A. Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 8: 339-46. PMID 11391304 DOI: 10.1067/Mnc.2001.113615  0.516
2001 Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, Lammertsma AA. Carbon-11 acetate as a tracer of myocardial oxygen consumption. European Journal of Nuclear Medicine. 28: 651-68. PMID 11383873 DOI: 10.1007/S002590000472  0.321
2001 Boellaard R, van Lingen A, Lammertsma AA. Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 808-17. PMID 11337581  0.307
2001 Lammertsma AA. PET/SPECT: functional imaging beyond flow. Vision Research. 41: 1277-81. PMID 11322972 DOI: 10.1016/S0042-6989(00)00262-5  0.421
2001 Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. European Journal of Nuclear Medicine. 28: 81-9. PMID 11202456 DOI: 10.1007/S002590000405  0.343
2001 Lammertsma AA. The Use of PET in Evaluating Tumor Response and Cancer Therapy Journal of Pharmacy Practice. 14: 361-367. DOI: 10.1106/Jk87-Xdxa-2839-6Lh8  0.365
2001 Heuvel OAvd, Veltman DJ, Cathfi DC, Dolan RJ, Witter MP, Groenewegen HJ, Lammertsma AA, Dyckt Rv. H2 150 PET symptom provocation study in obsessive compulsive disorder and Tourette's syndrome Neuroimage. 13: 1108. DOI: 10.1016/S1053-8119(01)92435-8  0.58
2000 Hoekstra CJ, Hoekstra OS, Lammertsma AA. On the use of the injection catheter for venous blood sampling in quantitative FDG PET studies. European Journal of Nuclear Medicine. 27: 1579. PMID 11083549 DOI: 10.1007/S002590000327  0.37
2000 Gunn RN, Lammertsma AA, Grasby PM. Quantitative analysis of [carbonyl-(11)C]WAY-100635 PET studies. Nuclear Medicine and Biology. 27: 477-82. PMID 10962254 DOI: 10.1016/S0969-8051(00)00115-3  0.389
2000 Hoekstra CJ, Paglianiti I, Hoekstra OS, Smit EF, Postmus PE, Teule GJ, Lammertsma AA. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. European Journal of Nuclear Medicine. 27: 731-43. PMID 10901462 DOI: 10.1007/S002590050570  0.368
2000 Wichter T, Schäfers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy : quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation. 101: 1552-8. PMID 10747349 DOI: 10.1161/01.Cir.101.13.1552  0.327
2000 Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, Pruim J, Price P. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. European Journal of Cancer (Oxford, England : 1990). 35: 1773-82. PMID 10673991 DOI: 10.1016/S0959-8049(99)00229-4  0.377
2000 Hoekstra CJ, Hoekstra OS, Lammertsma AA. On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies. European Journal of Nuclear Medicine. 26: 1489-92. PMID 10552093 DOI: 10.1007/S002590050484  0.357
1999 Choudhury L, Elliott P, Rimoldi O, Ryan M, Lammertsma AA, Boyd H, McKenna WJ, Camici PG. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. Basic Research in Cardiology. 94: 49-59. PMID 10097830 DOI: 10.1007/S003950050126  0.35
1999 Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage. 8: 426-40. PMID 9811559 DOI: 10.1006/Nimg.1998.0379  0.379
1998 Hermansen F, Rosen SD, Fath-Ordoubadi F, Kooner JS, Clark JC, Camici PG, Lammertsma AA. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. European Journal of Nuclear Medicine. 25: 751-9. PMID 9662598 DOI: 10.1007/S002590050279  0.335
1998 Schäfers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circulation Research. 82: 57-62. PMID 9440705 DOI: 10.1161/01.Res.82.1.57  0.342
1998 Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 6: 279-87. PMID 9417971 DOI: 10.1006/Nimg.1997.0303  0.364
1997 Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 4: 153-8. PMID 9345505 DOI: 10.1006/Nimg.1996.0066  0.322
1997 Hume SP, Brown DJ, Ashworth S, Hirani E, Luthra SK, Lammertsma AA. In vivo saturation kinetics of two dopamine transporter probes measured using a small animal positron emission tomography scanner. Journal of Neuroscience Methods. 76: 45-51. PMID 9334938 DOI: 10.1016/S0165-0270(97)00078-2  0.377
1997 Bloomfield PM, Myers R, Hume SP, Spinks TJ, Lammertsma AA, Jones T. Three-dimensional performance of a small-diameter positron emission tomograph. Physics in Medicine and Biology. 42: 389-400. PMID 9044420 DOI: 10.1088/0031-9155/42/2/010  0.425
1997 Pike VW, McCarron JA, Lammertsma AA, Osman S, Hume SP, Sargent PA, Bench CJ, Cliffe IA, Fletcher A, Grasby PM. Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. European Journal of Pharmacology. 301: R5-7. PMID 8773468 DOI: 10.1016/0014-2999(96)00079-9  0.373
1997 Hermansen F, Camici PG, Lammertsma AA. Polarmaps of myocardial blood flow from dynamic 6O-159water pet-studies Journal of Nuclear Cardiology. 4. DOI: 10.1016/S1071-3581(97)91166-1  0.343
1996 Hume SP, Ashworth S, Lammertsma AA, Opacka-Juffry J, Law MP, McCarron JA, Clark RD, Nutt DJ, Pike VW. Evaluation in rat of RS-79948-197 as a potential PET ligand for central α2-adrenoceptors European Journal of Pharmacology. 317: 67-73. PMID 8982721 DOI: 10.1016/S0014-2999(96)00710-8  0.305
1996 Bench CJ, Lammertsma AA, Grasby PM, Dolan RJ, Warrington SJ, Boyce M, Gunn KP, Brannick LY, Frackowiak RS. The time course of binding to striatal dopamine D2 receptors by the neuroleptic ziprasidone (CP-88,059-01) determined by positron emission tomography. Psychopharmacology. 124: 141-7. PMID 8935809 DOI: 10.1007/Bf02245614  0.342
1996 Ziegler SI, Haberkorn U, Byrne H, Tong C, Kaja S, Richolt JA, Byrne H, Tong C, Schosser R, Krieter H, Kaja S, Richolt JA, Lammertsma AA, Price P. Measurement of liver blood flow using oxygen-15 labelled water and dynamic positron emission tomography: limitations of model description. European Journal of Nuclear Medicine. 23: 169-77. PMID 8925852 DOI: 10.1007/Bf01731841  0.355
1996 Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T. The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. Journal of Neuroscience Methods. 67: 103-12. PMID 8872875 DOI: 10.1016/S0165-0270(96)00010-6  0.512
1996 Yamamoto Y, de Silva R, Rhodes CG, Iida H, Lammertsma AA, Jones T, Maseri A. Noninvasive quantification of regional myocardial metabolic rate of oxygen by 15O2 inhalation and positron emission tomography. Experimental validation. Circulation. 94: 808-16. PMID 8772705 DOI: 10.1161/01.Cir.94.4.808  0.543
1996 Jones T, Silbersweig DA, Stern E, Schnorr L, Seaward J, Clark JC, Lammertsma AA, Grootoonk S. The development of in vivo tracer methods to obtain new information about human disease: a study of the hallucinating brain. European Journal of Nuclear Medicine. 23: 332-5. PMID 8599966 DOI: 10.1007/Bf00837633  0.426
1996 Watabe H, Itoh M, Cunningham V, Lammertsma AA, Bloomfield P, Mejia M, Fujiwara T, Jones AK, Jones T, Nakamura T. Noninvasive quantification of rCBF using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 311-9. PMID 8594064 DOI: 10.1097/00004647-199603000-00017  0.532
1996 Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS. Comparison of methods for analysis of clinical [11C]raclopride studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 42-52. PMID 8530554 DOI: 10.1097/00004647-199601000-00005  0.309
1996 Blomqvist G, Lammertsma AA, Mazoyer B, Wienhard K. Effect of tissue heterogeneity on quantification in positron emission tomography. European Journal of Nuclear Medicine. 22: 652-63. PMID 7498227 DOI: 10.1007/Bf01254567  0.335
1996 Bench C, Lammertsma A, Pike V, Hume S, Cliffe I, Fletcher A, Grasby P. 11C-way 100635: A pet tracer for the 5HT1A receptor Schizophrenia Research. 18: 197-198. DOI: 10.1016/0920-9964(96)85617-9  0.363
1995 Rechavia E, de Silva R, Nihoyannopoulos P, Lammertsma AA, Jones T, Maseri A. Hyperdynamic performance of remote myocardium in acute infarction. Correlation between regional contractile function and myocardial perfusion. European Heart Journal. 16: 1845-50. PMID 8682017 DOI: 10.1093/Oxfordjournals.Eurheartj.A060838  0.486
1995 Hume SP, Opacka-Juffry J, Myers R, Ahier RG, Ashworth S, Brooks DJ, Lammertsma AA. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse (New York, N.Y.). 21: 45-53. PMID 8525461 DOI: 10.1002/Syn.890210107  0.332
1995 Lammertsma Aa, Hume SP, Myers R, Ashworth S, Bloomfield PM, Rajeswaran S, Spinks T, Jones T. PET scanners for small animals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2391-2. PMID 8523136  0.426
1995 Prevett MC, Lammertsma AA, Brooks DJ, Bartenstein PA, Patsalos PN, Fish DR, Duncan JS. Benzodiazepine-GABAA receptors in idiopathic generalized epilepsy measured with [11C]flumazenil and positron emission tomography. Epilepsia. 36: 113-21. PMID 7821267 DOI: 10.1111/J.1528-1157.1995.Tb00969.X  0.357
1995 Lassen NA, Bartenstein PA, Lammertsma AA, Prevett MC, Turton DR, Luthra SK, Osman S, Bloomfield PM, Jones T, Patsalos PN. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 15: 152-65. PMID 7798333 DOI: 10.1038/Jcbfm.1995.17  0.496
1995 MARINHO N, KEOGH B, COSTA D, ELL P, LAMMERTSMA A, CAMICI P. The pathophysiology of hibernating myocardium studied by PET during hyperinsulinemic-euglycemic clamp Journal of Nuclear Cardiology. 2: S3-S3. DOI: 10.1016/S1071-3581(05)80099-6  0.4
1994 Smith T, Tong C, Lammertsma AA, Butler KR, Schnorr L, Watson JD, Ramsay S, Clark JC, Jones T. Dosimetry of intravenously administered oxygen-15 labelled water in man: a model based on experimental human data from 21 subjects. European Journal of Nuclear Medicine. 21: 1126-34. PMID 7828623 DOI: 10.1007/Bf00181069  0.433
1994 Hume SP, Ashworth S, Opacka-Juffry J, Ahier RG, Lammertsma AA, Pike VW, Cliffe IA, Fletcher A, White AC. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. European Journal of Pharmacology. 271: 515-23. PMID 7705452 DOI: 10.1016/0014-2999(94)90813-3  0.33
1993 McFalls EO, Araujo LI, Lammertsma A, Rhodes CG, Bloomfield P, Pupita G, Jones T, Maseri A. Vasodilator reserve in collateral-dependent myocardium as measured by positron emission tomography. European Heart Journal. 14: 336-43. PMID 8458352 DOI: 10.1093/Eurheartj/14.3.336  0.512
1993 Galassi AR, Crea F, Araujo LI, Lammertsma AA, Pupita G, Yamamoto Y, Rechavia E, Jones T, Kaski JC, Maseri A. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. The American Journal of Cardiology. 72: 134-9. PMID 8328372 DOI: 10.1016/0002-9149(93)90148-6  0.472
1993 Lefroy DC, de Silva R, Choudhury L, Uren NG, Crake T, Rhodes CG, Lammertsma AA, Boyd H, Patsalos PN, Nihoyannopoulos P. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. Journal of the American College of Cardiology. 22: 1653-60. PMID 8227834 DOI: 10.1016/0735-1097(93)90591-N  0.302
1993 Ramsay SC, Murphy K, Shea SA, Friston KJ, Lammertsma AA, Clark JC, Adams L, Guz A, Frackowiak RS. Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task. The Journal of Physiology. 471: 521-34. PMID 8120819 DOI: 10.1113/Jphysiol.1993.Sp019913  0.329
1993 Bench CJ, Lammertsma AA, Dolan RJ, Grasby PM, Warrington SJ, Gunn K, Cuddigan M, Turton DJ, Osman S, Frackowiak RSJ. Dose dependent occupancy of central dopamine D2 receptors by the novel neuroleptic CP-88,059-01: a study using positron emission tomography and11C-raclopride Psychopharmacology. 112: 308-314. PMID 7871035 DOI: 10.1007/Bf02244926  0.329
1993 Lammertsma AA. Positron emission tomography. Brain Topography. 5: 113-7. PMID 1489639 DOI: 10.1007/Bf01129038  0.403
1992 Rechavia E, Araujo LI, De Silva R, Kushwaha SS, Lammertsma AA, Jones T, Mitchell A, Maseri A, Yacoub MH. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. Journal of the American College of Cardiology. 19: 100-6. PMID 1729318 DOI: 10.1016/0735-1097(92)90058-U  0.471
1992 Lammertsma AA, De Silva R, Araujo LI, Jones T. Measurement of regional myocardial blood flow using C15O2 and positron emission tomography: comparison of tracer models. Clinical Physics and Physiological Measurement : An Official Journal of the Hospital Physicists' Association, Deutsche Gesellschaft Fã¼R Medizinische Physik and the European Federation of Organisations For Medical Physics. 13: 1-20. PMID 1563217 DOI: 10.1088/0143-0815/13/1/001  0.518
1992 Lammertsma AA, Martin AJ, Friston KJ, Jones T. In vivo measurement of the volume of distribution of water in cerebral grey matter: effects on the calculation of regional cerebral blood flow. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 12: 291-5. PMID 1548301 DOI: 10.1038/Jcbfm.1992.39  0.469
1992 Wilson CB, Lammertsma AA, McKenzie CG, Sikora K, Jones T. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: a rapid and noninvasive dynamic method. Cancer Research. 52: 1592-7. PMID 1540969  0.368
1992 Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, Jones T. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 33: 1669-77. PMID 1517842  0.453
1992 Rechavia E, Galassi AR, Araujo LI, Halson P, Lammertsma AA, Jones T, Lavender JP, Maseri A. The significance of a dipyridamole induced 99mTc-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography. European Journal of Nuclear Medicine. 19: 1044-9. PMID 1464357 DOI: 10.1007/Bf00180866  0.557
1992 de Silva R, Yamamoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation. 86: 1738-42. PMID 1451245 DOI: 10.1161/01.Cir.86.6.1738  0.543
1992 Jones T, Tilsley DW, Wilson CB, Lammertsma AA, Brown G, Brady F, Price PM. Positron emission tomography for tumour assessment. Nmr in Biomedicine. 5: 265-9. PMID 1449966 DOI: 10.1002/Nbm.1940050512  0.533
1992 Hume SP, Lammertsma AA, Bench CJ, Pike VW, Pascali C, Cremer JE, Dolan RJ. Evaluation of S-[11C]citalopram as a radioligand for in vivo labelling of 5-hydroxytryptamine uptake sites. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology. 19: 851-5. PMID 1428913 DOI: 10.1016/0883-2897(92)90171-T  0.339
1992 Hume SP, Myers R, Bloomfield PM, Opacka-Juffry J, Cremer JE, Ahier RG, Luthra SK, Brooks DJ, Lammertsma AA. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse (New York, N.Y.). 12: 47-54. PMID 1411963 DOI: 10.1002/Syn.890120106  0.376
1992 Lammertsma AA, Jones T. Low oxygen extraction fraction in tumours measured with the oxygen-15 steady state technique: effect of tissue heterogeneity. The British Journal of Radiology. 65: 697-700. PMID 1393397 DOI: 10.1259/0007-1285-65-776-697  0.45
1991 Bench CJ, Price GW, Lammertsma AA, Cremer JC, Luthra SK, Turton D, Dolan RJ, Kettler R, Dingemanse J, Da Prada M, Biziere K, McClelland GR, Jamieson VL, Wood ND, Frackowiak RSJ. Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327 European Journal of Clinical Pharmacology. 40: 169-173. PMID 1906004 DOI: 10.1007/Bf00280072  0.342
1991 Lammertsma AA, Bench CJ, Price GW, Cremer JE, Luthra SK, Turton D, Wood ND, Frackowiak RSJ. Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography Journal of Cerebral Blood Flow and Metabolism. 11: 545-556. PMID 1904879 DOI: 10.1038/Jcbfm.1991.103  0.359
1991 Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, Iida H, Rechavia E, Galassi A, De Silva R, Jones T, Maseri A. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation. 83: 875-85. PMID 1900224 DOI: 10.1161/01.Cir.83.3.875  0.541
1991 Wilson CB, Snook DE, Dhokia B, Taylor CV, Watson IA, Lammertsma AA, Lambrecht R, Waxman J, Jones T, Epenetos AA. Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer. International Journal of Cancer. Journal International Du Cancer. 47: 344-7. PMID 1847121 DOI: 10.1002/Ijc.2910470305  0.489
1991 Galassi AR, Araujo LI, Crea F, Kaski JC, Lammertsma AA, Yamamoto Y, Rechavia E, Jones T, Maseri A. Myocardial blood flow is altered at rest and after dipyridamole in patients with syndrome X Journal of the American College of Cardiology. 17: A227. DOI: 10.1016/0735-1097(91)91873-D  0.433
1991 Galassi AR, Araujo LI, Lammertsma AA, Yamamoto Y, Rhodes CG, Jones T. Is the sensitivity of dipyridamole test imaging adversely affected by a submaximal coronary vasodilation? Journal of the American College of Cardiology. 17: A226. DOI: 10.1016/0735-1097(91)91870-K  0.42
1990 Lammertsma AA, Cunningham VJ, Deiber MP, Heather JD, Bloomfield PM, Nutt J, Frackowiak RS, Jones T. Combination of dynamic and integral methods for generating reproducible functional CBF images. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 10: 675-86. PMID 2384540 DOI: 10.1038/Jcbfm.1990.121  0.481
1990 Leenders KL, Perani D, Lammertsma AA, Heather JD, Buckingham P, Healy MJ, Gibbs JM, Wise RJ, Hatazawa J, Herold S. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain : a Journal of Neurology. 27-47. PMID 2302536 DOI: 10.1093/Brain/113.1.27  0.337
1990 Lammertsma AA, Mazoyer BM. EEC concerted action on cellular degeneration and regeneration studied with PET. Modelling expert meeting blood flow measurement with PET--Orsay, 12-13 October 1989. European Journal of Nuclear Medicine. 16: 807-12. PMID 1976517 DOI: 10.1007/Bf00833016  0.392
1990 Rechavia E, Araujo LI, Kushwaha S, Lammertsma A, Jones T, Mitchell A, Maseri A, Yacoub M. Dipyridamole-vasodilatory response in cardiac transplanted patients assessed by whole heart pet Journal of the American College of Cardiology. 15: A229. DOI: 10.1016/0735-1097(90)92634-E  0.451
1990 Rechavia E, Galassi AR, Araujo LI, Halson P, Lammertsma A, Jones T, Lavender P, Maseri A. The perfusion significance of spect-MIBI defect: quantitative validation with 15 O-water and pet Journal of the American College of Cardiology. 15: A228. DOI: 10.1016/0735-1097(90)92629-G  0.484
1990 Galassi AR, Araujo L, Lammertsma A, Yamamoto Y, Rhodes CG, Iida H, Jones T, Maseri A. Quantitative pet measurement of dipyridamole vasodilatory capacity in humans Journal of the American College of Cardiology. 15: A80. DOI: 10.1016/0735-1097(90)92036-2  0.497
1990 Price GW, Beach CJ, Cremer JC, Luthra SK, Turton DR, Lammertsma AA, Kettler R, DaPrada M, Wood N, Jamieson V, McClelland G, Frackowiak RSJ. Inhibition of brain monoamine oxidase-B by Ro19-6327 - in vivo measurerment using positron emission tomography European Journal of Pharmacology. 183: 166. DOI: 10.1016/0014-2999(90)92997-W  0.335
1989 Lueck CJ, Zeki S, Friston KJ, Deiber MP, Cope P, Cunningham VJ, Lammertsma AA, Kennard C, Frackowiak RS. The colour centre in the cerebral cortex of man. Nature. 340: 386-9. PMID 2787893 DOI: 10.1038/340386A0  0.337
1989 Baron JC, Frackowiak RS, Herholz K, Jones T, Lammertsma AA, Mazoyer B, Wienhard K. Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 9: 723-42. PMID 2684991 DOI: 10.1038/Jcbfm.1989.105  0.499
1989 Araujo LI, McFalls EO, Lammertsma AA, Jones T, Maseri A. Noninvasive Measurement of Coronary Flow Reserve in Patients with Coronary Artery Disease with 0–15 Water and Positron Emission Tomography (PET) Clinical Science. 76: 23P-23P. DOI: 10.1042/Cs076023Pa  0.5
1988 Lammertsma AA, Correia JA, Jones T. Stability of arterial concentrations during continuous inhalation of C15O2 and 15O2 and the effects on computed values of CBF and CMRO2. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 8: 411-7. PMID 3366802 DOI: 10.1038/Jcbfm.1988.77  0.464
1988 Lammertsma AA. Positron emission tomography and in vivo measurements of tumour perfusion and oxygen utilisation. Cancer Metastasis Reviews. 6: 521-39. PMID 3327631 DOI: 10.1007/Bf00047466  0.393
1987 Lammertsma AA, Baron JC, Jones T. Correction for intravascular activity in the oxygen-15 steady-state technique is independent of the regional hematocrit. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 372-4. PMID 3584270 DOI: 10.1038/Jcbfm.1987.75  0.436
1987 Lammertsma AA, Brooks DJ, Frackowiak RS, Beaney RP, Herold S, Heather JD, Palmer AJ, Jones T. Measurement of glucose utilisation with [18F]2-fluoro-2-deoxy-D-glucose: a comparison of different analytical methods. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 7: 161-72. PMID 3558499 DOI: 10.1038/Jcbfm.1987.39  0.49
1987 Wilson RA, Shea M, Landsheere CD, Deanfield J, Lammertsma AA, Jones T, Selwyn AP. Rubidium-82 myocardial uptake and extraction after transient ischemia: PET characteristics. Journal of Computer Assisted Tomography. 11: 60-6. PMID 3492521 DOI: 10.1097/00004728-198701000-00012  0.493
1986 Camici P, Araujo L, Spinks T, Lammertsma AA, Jones T, Maseri A. Myocardial glucose utilization in ischaemic heart disease: preliminary results with F18-fluorodeoxyglucose and positron emission tomography. European Heart Journal. 7: 19-23. PMID 3493137 DOI: 10.1093/Eurheartj/7.Suppl_C.19  0.512
1986 Camici P, Araujo L, Spinks T, Lammertsma AA, Sohanpal SK, Jones T, Maseri A. Prolonged metabolic recovery allows late identification of ischemia in the absence of electrocardiographic and perfusion changes in patients with exertional angina. The Canadian Journal of Cardiology. 131A-135A. PMID 3489509  0.397
1986 Herold S, Brozovic M, Gibbs J, Lammertsma AA, Leenders KL, Carr D, Fleming JS, Jones T. Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography. Stroke; a Journal of Cerebral Circulation. 17: 692-8. PMID 3488606 DOI: 10.1161/01.Str.17.4.692  0.506
1986 Brooks DJ, Beaney RP, Lammertsma AA, Turton DR, Marshall J, Thomas DG, Jones T. Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography. Microvascular Research. 31: 267-76. PMID 3487024 DOI: 10.1016/0026-2862(86)90016-6  0.521
1986 Camici P, Araujo LI, Spinks T, Lammertsma AA, Kaski JC, Shea MJ, Selwyn AP, Jones T, Maseri A. Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation. 74: 81-8. PMID 3486725 DOI: 10.1161/01.Cir.74.1.81  0.489
1986 Brooks DJ, Frackowiak RS, Lammertsma AA, Herold S, Leenders KL, Selwyn AP, Turton DR, Brady F, Jones T. A comparison between regional cerebral blood flow measurements obtained in human subjects using 11C-methylalbumin microspheres, the C15O2 steady-state method, and positron emission tomography. Acta Neurologica Scandinavica. 73: 415-22. PMID 3088902 DOI: 10.1111/J.1600-0404.1986.Tb03298.X  0.509
1986 Brooks DJ, Beaney RP, Lammertsma AA, Herold S, Turton DR, Luthra SK, Frackowiak RS, Thomas DG, Marshall J, Jones T. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 6: 230-9. PMID 3007547 DOI: 10.1038/Jcbfm.1986.36  0.457
1985 Leenders KL, Beaney RP, Brooks DJ, Lammertsma AA, Heather JD, McKenzie CG. Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization. Neurology. 35: 1610-6. PMID 4058751 DOI: 10.1212/Wnl.35.11.1610  0.325
1985 Lammertsma AA, Wise RJ, Cox TC, Thomas DG, Jones T. Measurement of blood flow, oxygen utilisation, oxygen extraction ratio, and fractional blood volume in human brain tumours and surrounding oedematous tissue. The British Journal of Radiology. 58: 725-34. PMID 3879853 DOI: 10.1259/0007-1285-58-692-725  0.465
1985 Spinks TJ, Lammertsma AA, Jones T, Rhodes CG, Hopkins NF. Influence of intravascular activity on the determination of blood flow and oxygen extraction in normal and ulcerated legs using the 15O steady-state technique and positron emission tomography. Journal of Computer Assisted Tomography. 9: 342-51. PMID 3871801 DOI: 10.1097/00004728-198503000-00022  0.493
1984 Lammertsma AA, Brooks DJ, Frackowiak RS, Heather JD, Jones T. A method to quantitate the fractional extraction of rubidium-82 across the blood-brain barrier using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 523-34. PMID 6438123 DOI: 10.1038/Jcbfm.1984.77  0.529
1984 Brooks DJ, Lammertsma AA, Beaney RP, Leenders KL, Buckingham PD, Marshall J, Jones T. Measurement of regional cerebral pH in human subjects using continuous inhalation of 11CO2 and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 458-65. PMID 6432811 DOI: 10.1038/Jcbfm.1984.65  0.503
1984 Kanno I, Lammertsma AA, Heather JD, Gibbs JM, Rhodes CG, Clark JC, Jones T. Measurement of cerebral blood flow using bolus inhalation of C15O2 and positron emission tomography: description of the method and its comparison with the C15O2 continuous inhalation method. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 224-34. PMID 6427237 DOI: 10.1038/Jcbfm.1984.31  0.48
1984 Wise RJ, Thomas DG, Lammertsma AA, Rhodes CG. PET scanning of human brain tumors. Progress in Experimental Tumor Research. 27: 154-69. PMID 6385123 DOI: 10.1159/000408228  0.326
1984 Brooks DJ, Beaney RP, Lammertsma AA, Leenders KL, Horlock PL, Kensett MJ, Marshall J, Thomas DG, Jones T. Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 535-45. PMID 6334092 DOI: 10.1038/Jcbfm.1984.78  0.489
1984 Lammertsma AA, Brooks DJ, Beaney RP, Turton DR, Kensett MJ, Heather JD, Marshall J, Jones T. In vivo measurement of regional cerebral haematocrit using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 4: 317-22. PMID 6332115 DOI: 10.1038/Jcbfm.1984.47  0.496
1984 Lammertsma AA. Positron emission tomography of the brain: measurement of regional cerebral function in man. Clinical Neurology and Neurosurgery. 86: 1-11. PMID 6325063 DOI: 10.1016/0303-8467(84)90270-1  0.363
Show low-probability matches.